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A small but growing number of bacteria and phages are known to contain linear, 
hairpin-ended genomes.  The hairpin “protelomeres” are created by the action of a 
dedicated enzyme known as protelomerase that acts on a palindromic DNA target 
sequence.  Phage protelomerases are typically longer than their bacterial counterparts and 
contain an additional far C-terminal region of limited sequence conservation.  Studies of 
the protelomerase of the Klebsiella oxytoca phage ΦKO2 have shown that although the 
far C-terminal region is not required to produce hairpin ends, truncation of the region has 
a drastic effect on enzyme kinetics.  To date, no other studies have been reported on the 
far C-terminal region of this or any other protelomerase.  We present the solution 
structures of the far C-terminal regions of two phage protelomerases.  The regions form 
homologous, compact structures that adopt a fold similar to the canonical double-
stranded RNA-binding domain and have been called the far C-terminal domains.  
Sequence alignment and secondary structure predictions show that all known and putative 
phage protelomerases contain C-terminal regions which will almost certainly form 
homologous domains.  A sequence comparison of these proteins with all known 
protelomerases is presented, along with an analysis of the sequence and structure of 
proteins which adopt a similar fold.  Based on structure homology and comparative 
sequence conservation of key binding regions, we propose that the domain belongs to the 
growing family of three stranded β-sheet DNA-binding proteins that is a subclass of the 
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The “chromosome end problem” 
Genomic stability rests upon the ability to replicate and repair a complete genome 
with fidelity.  Fidelity is ensured in both repair and replication by the action of a 
polymerase, which interprets the blueprint of a complementary strand to synthesize a new 
polynucleotide sequence.  Typically, the synthesis of a new strand by a polymerase also 
requires a primer, an existing oligonucleotide with a free 3‟-OH, on to which it adds 
additional nucleotides.  The necessity of an existing 5‟ primer results in a requirement for 
specialized care for terminal genomic DNA.  All known DNA polymerases operate in a 
5‟-3‟ direction.  Successive rounds of genomic replication lead to ongoing shortening of 
the lagging strand of linear DNA with subsequent eventual loss of genetic information 
(1).  Additionally, free or exposed genome ends are recognized by the cell as damaged or 
foreign DNA, and are subject to normal means of cellular protection and repair, including 
degradation by exonucleases and recombination via nonhomologous end joining (2, 3).  
The complications of replication and repair at regions of the terminal regions of genomes 
constitutes what has been called the “chromosome end problem.” 
Organisms across all kingdoms have developed different strategies for 
maintenance of genomic termini.  Typically, eukaryotes protect their linear genomes with 
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the addition of noncoding sequences to DNA ends.  Drosophila chromosomes, for 
instance, are maintained by the addition of a transposon sequence to the termini ((4, 5), 
and (6) for a recent review.)  More common is the insertion of repeated, guanine rich 
sequence regions which fold into specialized structures.  The folded structures interact 
with dedicated proteins, forming the protective nucleoprotein complexes called telomeres 
((7-9) for reviews).  Using an entirely different strategy, bacterial and Archaeal genomes 
are usually circular, bypassing the issue of exposed DNA ends entirely (summarized in 
(10).   
Although relatively rare, notable exceptions to this broad categorization of 
genome architecture are known.  There are several known examples, for instance, of 
bacteria with linear genomes.  Among these, there are two general methods used to 
protect exposed genomic termini. See Figure 1.1 for an overview of the classes of linear 
bacterial and phage genomes.  In the first class, as with linear eukaryotic chromosomes, 
terminal DNA ends are protected by associated proteins.  Representatives of this class 
include Streptomyces lividans (11) and Saccharopolyspora erythraea (12), in which the 
free ends of linear genomic DNA are protected by 5‟ covalent association with “terminal 
proteins” (TPs.)  Some viral pathogens also employ this method, including adenovirus 
(13) and Bacillus subtilis phage Φ29 (14).  Under this means of genome protection, the 
covalently attached proteins also serve to prime DNA synthesis during replication.  In 
adenovirus and phage Φ29 replication, the attached protein is the origin of replication, 
while in Streptomyces, replication initiates from an interior location, and the attached 
terminal protein serves to help initiate “end patching” of the single-stranded region that 












Figure 1.1  Approaches to the “chromosome end problem” by bacteria and viruses  
Circular genome without free ends  
Linear genome with distal ends 
protected by a protein covalently 
attached to the 5‟- ends 
Linear genome with covalently 
closed hairpin ends  
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chromosome.)  Another solution to the chromosome end replication problem has also 
been discovered in both bacteria and viruses with linear genomes.  In these systems, the 
termini of linear chromosomes or plasmids are covalently closed and protected by 
terminal “hairpin caps,” which prevent both exonucleolytic degradation and terminus 
shortening during replication (17, 18).  The hairpin caps have been shown to be 
covalently closed by a combination of denaturation/renaturation studies, direct visual 
examination of denatured, single stranded circles through microscopy, and Maxam-
Gilbert sequence analysis (19-21).  Because of the protection afforded the genome 
termini by the hairpin caps, the term “protelomere” was coined to represent “prokaryotic 
telomeres” (22).   
 
Hairpin-capped genomes and their protelomeres 
In all systems so far studied, replication of a linear, hairpin-ended genome is 
relatively simple.  Common replication enzymes initiate bi-directional replication at an 
interior location of origin resulting in a circular, concatenated genomic dimer (23, 24).  In 
vitro assays have shown that the interlinked genome is resolved into monomers by the 
action of a single dedicated enzyme (17, 25-29).  The process of resolution into 
monomers produces the terminal hairpin ends, so the enzyme has been called both a 
“protelomerase” and a “telomere resolvase” (25, 26).  The presence of a protelomerase-
type protein in a bacterium is a good indication that the system carries a linear replicon.  
Table 1.1 lists the known protelomerases and the organisms in which they were found, 
and gives a brief description of each system. 
 
.
 Table 1.1 
 
Organisms that contain known or putative protelomerases 
 
Organism Enzyme length Description 
Borrelia burgdorferi 449 A gram-negative spirochetal bacteria that is a significant, tick-borne, human pathogen and the 
causative agent of Lyme disease (30).  Symptoms of Lyme disease include fever, chills, headache, 
and musculoskeletal pain.  Progressive illness results in facial palsy, arthritis, heart palpitations, 
and chronic neurological complaints, including tremor and short term memory loss.  Infections 
have been associated with non-Hodgkin lymphoma.(31)  The fragmented genome consists of both 
circular and linear chromosomes plus 12 linear and nine circular plasmids (19, 20, 32-34).  The 
protelomerase gene (called ResT) is essential for B. burgdorferi survival (35, 36). 
Borrelia hermsii 449 A gram-negative, spirochetal bacteria and a significant, tick-borne human pathogen, B. hermsii is 
the causative agent of relapsing fever.  Manifestations include headache, myalgia, arthralgia, 
chills, vomiting, and abdominal pain (37, 38).   
Agrobacterium 
tumifaciens 
442 A rod-shaped, gram-negative bacterium of the family Rhizobiaceae found ubiquitously in soil, A. 
tumefaciens causes crown gall disease in plants by inserting a fraction of its DNA (called T-DNA) 
in the host genome (39, 40).  The wide variety of plants affected by the bacterium (including grape 
vines, stone fruits, nut trees, sugar beets, horseradish, and rhubarb) makes it of great concern to 
the agriculture industry (41).  The segmented genome consists of one linear and one circular 
chromosome, and two circular plasmids. 
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 Table 1.1 continued   
Organism Enzyme length Description 
Escherichia coli phage 
N15 
630 A non-integrative, temperate, lambdoid-like phage of the Siphoviridae family (22, 42).  E. coli is a 




520 A myovirus-like temperate phage induced from H. aquamarina, the gram-negative halophilic 
gammaproteobacterium that has been isolated from a variety of marine and hypersaline 
environments, including the pelagic ocean, deep-sea hydrothermal vents, the brine-seawater 
interface of deep-sea brine pools, and coastal surface waters.  The PhiHAP-1 genome shares 
synteny and gene similarity with coliphage N15 and vibriophages VP882 and VHML (43). 
Klebsiella oxytoca 
phage ΦKO2 
640 A non-integrated prophage of K. oxytoca with a genome size of approximately 51.6kb.  Genome 
organization is similar to the coliphage N15 (44).  K. oxytoca is a gram-negative, rod-shaped 
bacterium closely related to K. pneumoniae 
Vibrio harveyi phage 
VHML 
509 VHML (Vibrio harveyi myovirus like) is a temperate phage classified in the Myoviridae family.  It 
infects the free living gram-negative marine bacterium V. harveyi, which causes the normally non-
pathogenic host to become virulent to a variety of aquatic organisms (45).  Economic loss in recent 
years due to infection of aquacultured species has been particularly devastating (46, 47).  The phage 
was sequenced, but the host-phage system was reported as lost (43).  VHML has also been reported 
to lyse the strains  the strains Vibrio alginolyticus ACMM102 and Vibrio cholerae ATCC 14035. 
Vibrio 
parahaemolyticus 
O3:K6 phage VP58.5 
 A 42.612 kb myovirus closely related to VHML that was isolated from a V. parahaemolyticus strain 
belonging to the serovar O3:K6 pandemic clonal complex.  The clone has been associated with 
many seafood-borne diarrhea outbreaks in Southeast Asia and South America, particularly Chile 
(48).   
   
   6 
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Table 1.1 continued 
Organism Enzyme length Description 
Vibrio 
parahaemolyticus 
O3:K6 phage VP882 
538 A Myoviridae bacteriophage isolated from a pandemic strain of V. parahaemolyticus that also 
infects and lyses high proportions of Vibrio vulnificus and Vibrio cholerae (49).  V. 
parahaemolyticus is a gram negative, rod-shaped, motile, facultatively aerobic bacterium found in 
brackish saltwater.  When ingested, it causes gastrointestinal illness in humans.  Wound, eye, and 




617 Yersinia enterocolitica is a member of the family Enterobacteriaceae, some strains of which are 
enteropathogenic to humans, and are predominantly transmitted by ingestion of undercooked meat 
(51, 52).  Non-pathogenic strains are found readily in the environment and may have potential to 
become pathogenic. PY54 is a linear plasmid prophage with a genome size of approximately 46kb 
which infects Y. enterococolitica. (53) 
Vibrio campbelli 691 A gram-negative, facultative anaerobe which contains a putative protelomerase (DBSOURCE 
accession code ABGR01000073.1.)  It is likely that the protelomerase is encoded by a phage 





Creation and maintenance of hairpin protelomeres 
Creation and maintenance of a hairpin protelomeres requires only a protelomerase 
and the DNA recognition sequence upon which it acts.  Indeed, normally circular 
plasmids which have been engineered to encode the Escherichia coli phage N15 
protelomerase and its DNA recognition sequence have been shown to linearize in vivo 
once transformed into E. coli, and to replicate stably as hairpin-ended linear plasmids 
(18).  The DNA binding site of all known protelomerases is a palindromic inverted repeat 
at the junction of the genomic dimers (see Figure 1.2).  Studies on the protelomerases 
from the ΦKO2 and N15 phages and from the bacterial Borrelia burgdorferi enzyme 
(usually called ResT) have shown that the protelomerase enzymes, which are monomeric 
in solution, bind target DNA as dimers, creating transient staggered cuts six base-pairs 
apart on opposite strands, each three base-pairs away from the axis of dyad symmetry of 
the palindrome (29, 54, 55).  The 6 bp overhangs created by the staggered cuts fold over 
and are joined to the opposite strand to form the hairpin caps. 
 
Protelomerase nearest neighbor and reaction mechanism 
Protelomere resolvases share sequence homology and an expected two-step 
reaction mechanism with the site-specific integrases called tyrosine recombinases or 
lambda integrases, as well as with type IB topoisomerases (28, 29, 56-58) (see also (59) 
for a minireview.)  Site-specific tyrosine recombinases/lambda integrases are tetrameric 
and bind to two duplex DNAs, catalyzing the exchange of four DNA strands to integrate 
or excise a DNA segment from the host genome (60, 61).  IB topoisomerases are found 
across eukarya, in many bacterial genera, and two known families of eukaryotic viruses
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Figure 1.2  Schematic:  Protelomerases resolve replicated DNA to form hairpin telomeres 
Based on the figure from Aihara et al, Molecular Cell, Volume 27, Issue 6, 21 September 
2007, Pages 901-913 
A)  Cartoon showing the current understanding of replication of hairpin telomere-
containing linear genomes.  Replication of a linear chromosome with hairpin telomeres 
produces a dimeric circular intermediate that is resolved into unit-length chromosomes by 
the activity of protelomerase.  L and R refer to left and right hairpin ends, respectively. 
B)  A model for the hairpin formation reaction by the protelomerase Tel-KO2, proposed 
based on the crystal structure presented in the study.  The dots represent the phosphates at 
the sites of cleavage. 
R’ 
linear chromosome 














replication results in a junction   
    of concatenated dimers 
junctions 
protelomerase resolves dimer  
    and creates hairpin ends 
L/L‟ junction of replicated, concatenated 
chromosomes and protelomerase 
monomers showing reactive tyrosines 
L  
 
reaction intermediate is a covalent 
        phosphotyrosine linkage 
spontaneous folding/reaction forms hairpin 
     ends and releases reactive tyrosines 
protelomerase dimer binding distorts DNA 





 (poxvirus and mimivirus, (59, 62).)  Type IB topoisomerases are monomeric, and act to 
relax supercoiling by cleaving and rejoining a single strand of duplex DNA, which is first 
allowed to rotate relative to the opposite strand (63).  The reaction mechanism for all 
three enzyme families is similar.  A conserved catalytic pentad (R-K-R-H-Y) acts to 
execute the cleavage and religation of DNA by way of consecutive transesterification 
reactions without the use of a cofactor.  In the reaction, a nucleophilic attack by a 
catalytic tyrosine on the scissile phosphodiester bond within the DNA target site results 
in the formation of a covalent 3‟ DNA-phosphotyrosyl linkage and a free 5‟ hydroxyl.  In 
the second half of the reaction, the free 5‟ hydroxyl from the same strand (IB 
topoisomerases), complementary strand (protelomerases), or a strand from a neighboring 
duplex (lambda integrases) attacks the phosphotyrosyl intermediate in a second 
nucleophilic reaction, regenerating a joined DNA strand and releasing the catalytic 
tyrosine. 
 
Protelomerase domain organization 
All known protelomerases contain a highly conserved central region surrounded 
by N-terminal and C-terminal regions of variable length, sequence, and secondary 
structure prediction.  Protelomerases can be roughly broken into two clades based 
primarily on size.  The bacterial protelomerases are shorter, approximately 450 residues 
in length,  while phage protelomerases are longer; most consist of more than 600 
residues.  The phage protelomerases contain an additional C-terminal region of varying 
length which terminates in a short region of moderate conservation.  The conserved 
central core is highly homologous to tyrosine recombinases and Type IB topoisomerases, 
and contains all five of the catalytic pentad residues. 
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Protelomerase structure 
The crystal structure of the minimally catalytic, N-terminal portion (531 of 640 
residues) of the Klebsiella oxytoca phage ΦKO2 protelomerase (Tel-KO2) complexed to 
the central 44 base-pairs of its 50 base-pair DNA target site was recently solved (64).  To 
“trap” the enzyme in an intermediate state, the DNA target was nicked, and contained 
orthovanadates (VO4
3-
) to mimic the pentavalent transition state of the scissile DNA 
phosphate cleavage.  The crystallography was simplified by slightly altering the DNA 
sequence to make it symmetric (two bases on each side normally interrupt the otherwise 
perfect symmetry) with an additional nucleotide substitution at the distal end.  The 
structure shows two interlocked Tel-KO2 monomers each bound to a half-site of the 
DNA target (see Figure 1.3).  The dimerically bound proteins show extensive interprotein 
subunit and protein-DNA contacts.  The Tel-KO2 monomer subunits bind to their DNA 
target with their C-terminal domains on the distal ends of the DNA target site and the N-
terminal domains interlinking near the central six base-pairs of the target site.  Each 
monomer contains an extended linker helix (K) in between its first and second domains.  
When the monomer binds to its target site, helix K rests in the major groove, allowing the  
monomer to wrap completely around the DNA while still remaining predominantly on 
one side of the DNA.  The authors propose that the enzyme dimer functions by bending 
and “springloading” the DNA, and that following nicking, the 6 base-pair, 5‟-
overhanging ends reorganize spontaneously within the enzyme active site, allowing the 
protelomerase to act as a ligase to produce two hairpins ends from the original duplex 
DNA.  The authors further surmise that the reaction is made essentially irreversible 










Figure 1.3  Structure of the Tel-KO2 Dimer Bound to DNA.   
A) “Bottom view” of the structure oriented parallel to the two-fold non-crystallographic 
axis with the DNA helix extending horizontally from left to right, showing the extensive 
coverage of the DNA by the protelomerase dimer.   
B) “Side view” of the structure (rotated 90° along the z-axis relative to the view in (A)) 
showing the protein-induced curvature of the DNA.  DNA nicking sites are indicated.   
C)  “Top view” of the structure (rotated 90° along the z axis relative to the view in (B)) 
showing the offset in the DNA helical axis, highlighted by dotted lines indicating the 
axes for each half-site.  In all views, one monomer is colored grey while the second 
monomer is colored with a spectrum in which the N-terminus begins in blue and the C 
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which they presume is induced by protein-binding.  The DNA is not only bent in a curved 
arc (73° within a plane parallel to the two-fold axis of the complex), but the ends are bent 
outward from their otherwise linear path.  The structure indicates that the disruption of 
the dimer interface may be required for hairpin formation following initial strand 
cleavage.  The Tel-KO2 monomers are described as having three domains: an amino-
terminal domain, the central portion of which the authors refer to as the “muzzle,” the 
highly conserved catalytic domain containing all five residues which constitute the 
catalytic pentad, and a carboxy-terminal domain, which the authors call the “stirrup” (see 
Figure 1.4).  The linker helix K connects the N-terminal and catalytic domains.  The C-
terminal/stirrup domain is connected to the catalytic domain by an extended segment.  
The “stirrup” contacts the DNA, but does not interact extensively with other portions of 
the protein.  The carboxy end of the stirrup domain seems to loop back toward the 
catalytic domain, but there is no known or presumed function for this configuration, 
which may or may not be an artifact of the shortened construct.  The protelomerase dimer 
extensively covers the DNA, with the exception of a small, 8-9 basepair stretch of the 
target site eleven basepairs from either side of the palindrome center.   
The domain organization of the Tel-KO2 protein monomers is similar to, but 
distinct from, the lambda integrase/tyrosine recombinases with which protelomerase 
resolvases share sequence homology.  The core portion of lambda integrase consists of a 
two-lobed architecture consisting of an amino-terminal domain (sometimes called a core-
binding domain) and a catalytic, or core domain, connected by an extended linker (60).  
The catalytic domains of the lambda integrase and Tel-KO2 proteins are especially well-








Figure 1.4  Surface of the Tel-KO2 dimer.   
The figures are colored as follows:  monomer 1:  N-terminal muzzle domain in blue, 
linker helix in green, catalytic domain in yellow, and C-terminal stirrup domain in red; 
monomer 2:  N-terminal muzzle domain in cyan, linker helix in gray-green, catalytic 
domain in orange, and C-terminal stirrup domain in purple.  The views are oriented 
identically to those in figure X.X as follows: 
A) Bottom view of the dimer, showing the extensive coverage of the DNA binding site 
by Tel-KO2, and the interactions of the catalytic domains (colored orange and yellow) of 
the monomer subunits.   
B) Side view of the dimer, showing that while each monomer wraps around the DNA, 
each monomer lies predominantly on one side of the DNA arc.   
C) Top view of the dimer, showing the extensive interaction of the N-terminal muzzle 
domains (colored blue and cyan) with each other, which also interact with the DNA on 
the neighboring half-site.  Each N-terminal muzzle domain cradles the linker helix K of 
its neighbor helix. 
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observable in a calculated DaliLite Pairwise comparison (see Figure 1.5) (65).  However, 
the structures differ in several instances.  Lambda integrase does not contain a 
homologous carboxy terminal “stirrup” domain, and the amino-terminal/core-binding 
domain is much smaller, seemingly lacking the majority of the “muzzle” present in 
protelomerase KO2 (helices D-I, residues 79-200).  Additionally, lambda integrase 
contains an amino terminal arm-binding domain not present in Tel-KO2, which is 
connected by an extended linker.  This domain is crucial to the functioning of lambda 
integrase.  It interacts with the arm-binding domains of three other integrase subunits to 
form a functioning tetramer that binds the accessory (arm) DNAs involved in 
recombination.  The arm-binding tetramer/accessory DNA interaction appears to shape 
the recombination complex in a way that suggests arm binding shifts the reaction 
equilibrium in favor of recombinant products (60).  
 
Preliminary work 
Far C-terminal region 
The length of the Tel-KO2 construct used for crystallographic analysis 
represented the shortest construct shown to be catalytically active during in vitro deletion 
studies (Huang, W.M., personal communication, unpublished data.)  The studies show 
that C-terminally truncated enzyme can resolve oligomer substrates containing the full-
length Tel-KO2 target site into hairpin products in vitro.  All deletion mutants studied 
(truncated to 605, 545, 538, and 531 from the full length 640-residue protein) are able to 
produce hairpins in the in vitro assay.  However, a resolution kinetics comparison study 
of the shortest truncation (TelK531) with full length (TelK640) enzyme show that while 












Figure 1.5  Domain architecture comparison of the published structures of the C-
terminally truncated Klebsiella oxytoca phage ΦKO2 protelomere resolvase (Tel-KO2) 
and lambda integrase as calculated in a DaliLite pairwise comparison.  
(A) Superposition of monomers.  The Tel-KO2 monomer is shown in light cyan and the 
integrase monomer is shown in red.   
(B) Close-up view of conserved catalytic regions, which have been rotated 90° along the 
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reduced, and functions only at approximately 1/50
th
 the rate of full-length enzyme (see 
Figure 1.6.)  
The Huang group also studied the effect of truncating the DNA target site on 
protelomerase K function.  An in vitro analysis revealed that distally truncating the DNA 
target site by as little as three base pairs on both sides of the palindromic 56 base-pair 
target sequence reduced the efficiency of full-length Tel-KO2 (1-640) by 75%.  Further 
truncating the DNA target site to contain only the central 42 base pairs (seven base-pairs 
removed from each end) decreased efficiency of Tel-K640 to less than 1%.  Surprisingly, 
the most highly truncated enzyme (TelK531) was better able to process the shortened 
target site substrates, with an efficiency that was restored to nearly 15% of full-length 
Tel-KO2 acting on full-length oligomer substrates (see Figure 1.7).  Since this 
combination permitted catalytic activity (although kinetic efficiency was reduced 
compared to full length protein and substrate), a C-terminally truncated Tel-KO2 and a 
minimal DNA target were selected for structural studies by crystallographic analysis.   
Although a truncated Tel-KO2 was found to be sufficient for processing truncated 
DNA target sites in vitro, the unique effects of the C-terminal region on the function of 
Tel-KO2 in substrate processing indicated that this region warranted further study.  
Removal of the C-terminal domain negatively affects the ability of Tel-KO2 to produce 
hairpins from linear, double-stranded target DNA, and the distal ends of the target site 
also have an effect on catalysis that cannot be explained by interaction with the 
catalytically active portion of the protelomerase.  Given the in vitro study results, it seems 
probable that the far C-terminal region of the protelomerase interacts with the distal DNA 











Figure 1.6  Comparison of the kinetics of hairpin resolution of replicated oligonucleotide 
substrate by full length (1-640) and truncated (1-531) Tel-KO2.   
The oligonucleotide target sequence contains the full length 56 base pair binding site plus 
an additional ten base-pairs for better visualization of the resulting hairpins.  Hairpin 
turnover by  truncated Tel-KO2 occurs at 1/50
th
 the rate of full length (1-640) Tel-KO2.   
A) Agarose gels comparing resolution progression.   
B) Reaction profile showing the rate of truncated Tel-KO2(1-531) activity (squares) 
compared to the rate of full-length Tel-KO2 (1-640) activity (circles).  Activity is scaled 
to percent hairpin formation of wild type (full-length) Tel-KO2.  Wai Mun Huang lab, 





































Figure 1.7  Effect of DNA target site truncation on efficiency of Tel-KO2 hairpin 
resolution.   
Reducing the length of the oligomer substrate decreases the efficiency of full-length Tel-
KO2 in hairpin resolution.  A C-terminally truncated Tel-KO2 (1-531) can partially 
restore efficiency for the shortest truncated substrate. 
Lanes 1-4:  oligonucleotide substrate contains full-length (50 base pair) binding site.  
Lanes 5-8:  Tel-KO2 binding site contained in the oligonucleotide substrate has been 
truncated by three base-pairs on either end.  Resulting oligonucleotide contains the 
central 50 base-pairs of the Tel-KO2 binding site.  Lanes 9-14:  Tel-KO2 binding site 
contained in the oligonucleotide substrate has been truncated by seven base-pairs on 
either end.  Resulting oligonucleotide contains the central 42 base-pairs of the Tel-KO2 
binding site.  Lanes 1, 5, and 9:  no protelomerase added.  Lanes 2-4 and 6-8:  increasing 
amounts of full length Tel-KO2 were titrated with the corresponding oligomer substrate.  
Lanes 10-12:  A much greater higher concentration of Tel-KO2 used in lanes 2-4 and 6-8 
was incubated with the 42 base-pair oligomer.   Lanes 13 and 14:  Truncated Tel-KO2 (1-
531) was incubated with the 42 base-pair oligomer.  Efficiency of activity of the full-
length and truncated Tel-KO2 enzymes is shown as a percentage of efficiency of full-
length enzyme acting on full-length oligomer substrate. 
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contains an unusually high number of acidic residues and was deemed unsuitable for 
crystallographic analysis, so structural studies by NMR were proposed in order to 
elucidate the function of this interesting domain.  
 
Research overview 
Although they are relatively rare, the number of phage and bacterial organisms 
known to use covalently closed hairpin ends as a way of protecting their linear genomes 
is growing, and this means of genomic conservation is just beginning to be understood.  
The creation and maintenance of hairpin ends is accomplished by the action of a single, 
dedicated enzyme known as a protelomere resolvase, or protelomerase.  A sequence 
alignment of protelomerases from phage and bacterial origins reveals that phage 
protelomerases are generally longer, and contain an additional C-terminal region 
consisting of a linker of variable length terminating in a short region of limited 
conservation.  We have called this region the far C-terminal domain (farCTD.)  The role 
of this extended region is not understood, but studies of the protelomerase from 
Klebsiella oxytoca phage ΦKO2 have shown that truncating the far CTD has drastic 
effects on enzyme functioning in in vitro studies.  Protelomerase constructs lacking the 
far C-terminal domain can function in vitro to produce hairpins from synthetic DNA 
oligomers containing the native protelomerase binding site, but the truncated 
protelomerase functions at only a fraction of the normalized activity of the full length 
enzyme.  Additionally, truncating the DNA binding site in synthetic DNA oligomers also 
dramatically decreases the efficiency of the protelomerase in a manner that cannot be 
explained by interaction with the catalytic portion of the molecule described in the solved 
structure.  The function of the far C-terminal region is unknown.  However, the 
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comparative in vitro studies of truncated and full-length protelomerase indicate that the 
far C-terminal region of Tel-KO2 plays an important role in enzyme function, either 
through interaction with the catalytic portion of the protelomerase, or with the DNA 
target itself.   
To understand the role of the far C-terminal domain, we have asked a number of 
questions.  How much of the C-terminal region of phage protelomerases is structured, 
and what is the structure of this domain?  How much sequential and structural 
conservation is there between the far C-terminal domain of the Klebsiella oxytoca phage 
ΦKO2 protelomerase and those of other phage protelomerases?  What is the likely 
binding partner of the protelomerase far CTD?  And lastly, what relation does the phage 
protelomerase far CTD have to the bacterial protelomerase?  
Chapter two reports my work on this project in attempting to answer these 
questions.  We report the solution structure of the far CTD of two phage protelomerases.  
A comparison of the sequence of these protelomerase domains to the homologous regions 
of all known phage protelomerases is presented.  We also include information about 
likely structural analogues in other proteins, a report of initial studies seeking to identify 










STRUCTURES OF THE KLEBSIELLA OXYTOCA PHAGE  
ΦKO2 AND VIBRIO HARVEYI PHAGE VHML  




We present the solution structures of the far C-terminal domains of two phage 
protelomerases.  A sequence comparison of these structures with all known 
protelomerases is presented, along with an analysis of the sequence and structure of 
proteins which adopt a similar fold.  The solution structures show that the far C-terminal 
domain of phage protelomerases adopts a fold which is similar to the canonical dsRBD.  
Based on structure homology and limited sequence conservation, we propose that the 
domain belongs to the growing family of three stranded β-sheet DNA-binding proteins.   
 
Introduction 
A small but growing number of bacteria and viruses have been discovered to have 
linear genomes protected by covalently closed hairpin ends.  The hairpin ends function 
like eukaryotic telomeres in protecting the genome from aberrant recombination and 
repair as well as from exonucleolytic degradation and have therefore been called 
“protelomeres” (17-22, 43).  In organisms which employ this method of genomic 
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protection, bidirectional replication results in a concatenated genome dimer that is 
resolved into unit lengths by the action of a single, dedicated enzyme called a 
protelomere resolvase (protelomerase) (23, 24, 26-29, 54).  The protelomerase binds as a 
dimer on a palindromic DNA sequence at the end-to-end junctions of the genome dimers 
and acts to produce and maintain the hairpin caps following replication.   
Known protelomerases have a similar architectural domain organization.  
Protelomerases have a highly conserved central catalytic region, with amino and carboxyl 
regions of varying length and conservation.  Phage protelomerases tend to be longer than 
their bacterial homologues, and have an additional region of varying length with limited 
sequence homology at the far C-terminal end of the protein.  Although the presence of 
this far C-terminal region is universally conserved in phage protelomerases, the purpose 
of the domain is not yet understood.  So far, only two studies regarding the far C-terminal 
domain (farCTD) have been undertaken, and both were in the Klebsiella oxytoca phage 
ΦKO2 system.   
Current analyses of the ΦKO2 system show that the far C-terminal region is not 
required for catalytic activity, but that its absence has a dramatic negative effect on 
enzyme function.  In vitro studies of the protelomerase of the Klebsiella oxytoca phage 
ΦKO2 (Tel-KO2, also called TelK) have shown that although a truncated protelomerase 
lacking this far C-terminal region is sufficient to form hairpins from synthetic double-
stranded DNA oligomers containing the protelomerase recognition site, the efficiency of 
the enzyme is severely affected by shortening or removal of the far C-terminal region.  
Constructs lacking the far C-terminal region function at less than 1/10
th
 the rate of full 
length enzyme (Wai Mun Huang, personal communication, unpublished data).   
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Other protelomerase analyses are not explained by the current understanding of 
the catalytic region.  The structure of C-terminally shortened protelomerase Tel-KO2 
(lacking the far C-terminal region) bound to the central 44 basepairs of its target site was 
recently described (64).  The structure indicates that the catalytic portion of the enzyme 
extends only to the central 42 base pairs of the normally 56 base pair target site.  
However, shortening the DNA target site has a dramatic negative effect on enzyme 
function (Wai Mun Huang, personal communication, unpublished data).  In vitro assays 
measuring the ability of protelomerase to create hairpins from double-stranded oligomers 
containing the target site show that shortening the length of the DNA target site by as few 
as three base pairs per side reduces percent enzyme activity to only 25% of that of full-
length protelomerase acting on full length (56 base pair) target site.  Shortening the target 
site further (seven basepairs per side, resulting in a 42 basepair target site) reduces 
enzyme function even more, to less than 1% activity.  The solved structure does not 
explain how the external regions of the DNA affect enzyme efficiency.  Interestingly, 
enzyme constructs lacking the far C-terminal region were able to partially restore enzyme 
efficiency for shortened DNA oligomers in in vitro assays.  Together, the data suggest 
that the far C-terminal region of protelomerase Tel-KO2 may interact with the distal 
regions of the DNA palindrome, the catalytic region, or both in a manner that influences 
protelomerase catalytic ability.  Secondary structure predictions of the far C-terminal 
region of Tel-KO2 and other protelomerases estimate a region of flexibility but the 
varying length and limited sequence conservation of the C-terminal region make it 
difficult for automated sequence alignment programs to compare the far C-terminal 
regions.  No further information has been reported about the structure or function of the 
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far C-terminal region of this or any protelomerase.   
To better understand the role of the far C-terminal region in the functioning of  
phage protelomerases, we determined which portions of the isolated Tel-KO2 far C-
terminal region are well-structured and we report the solution structure of this region.  To 
verify the structure, we also solved the solution structure of a homologous region of a 
second phage protelomerase.  We report that the structures form compact domains that 
adopt a similar fold and belong to the double stranded RNA binding domain (dsRBD)-
like superfamily.  We present an alignment of these domains with the far C-terminal 
regions of all known phage protelomerases, identifying putative homologous far C-
terminal domains (farCTDs) and identify conserved residues.  We propose by structural 
homology and limited sequence conservation that the protelomerase farCTD belongs to 
the small but growing group of proteins which recognize DNA in a sequence-specific 
way by inserting a three-stranded β-sheet in the DNA major groove.   
 
Experimental procedures 
DNA, plasmids, and cloning 
DNA encoding the Tel-KO2 far C-terminal region was amplified from established 
vectors encoding full-length Tel-KO2 (cloning of vectors described in (29)).  The length 
of the initial Tel-KO2 farCTD construct (residues 530-640 in the context of the full-
length protelomerase) was selected to overlap the amino-terminal region of the 






N-NOE (heteronuclear NOE) experiments combined with a standard 
suite of NMR assignment experiments (described below) were used to identify the 
structured portion of the Tel-KO2 farCTD.  The length of the construct selected for 
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structure determination (residues 581-640) was predicted to have a short N-terminal 
unstructured region.  The size of the protein fragment used to study the VHML 
protelomerase farCTD (Tel-VHML, residues 449-509) was selected to reflect the solved 
structure of the Tel-KO2 far CTD as determined by direct sequence and predicted 
secondary structure homology.  The encoding DNA was amplified from PCR primers 
designed by Wai Mun Huang and synthesized as oligonucleotides by the University of 
Utah DNA/Peptide core facility. 
The resulting DNA fragments encoding either Tel-KO2 or Tel-VHML farCTD 
were ligated into NdeI/BamHI sites of T7 promoter-driven pET16b vectors (Invitrogen) 
to create a template that encoded a fusion protein with an amino-terminal 6X histidine 
affinity tag followed by a thrombin protease site. By design, the purified proteins 
contained an additional four amino-terminal residues (G-S-H-M) resulting from the 
thrombin cleavage site. The expression constructs were verified by DNA sequencing at 
the University of Utah DNA Sequencing Core facility, and resulting plasmids were 
transformed into E. coli BL21 (DE3) Gold Competent cells (Novagen.) 
 
Protein expression and purification 
Tel-KO2 or Tel-VHML protelomerase farCTD fusion proteins were isolated from 
cells grown in two-liter quantities of M9 minimal media supplemented with 130 µg/ml 
ampicillin and either 2g/liter 
13
C-glucose and 1g/liter 
15
NH4Cl or 1g/liter 
15
NH4Cl alone.  
Cells harboring the Tel-KO2 plasmid grew at 37°C to a cell density of approximately 
A[590] = 0.8.  Protein expression followed induction by 0.7 mM (final concentration) 
isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 12–16 hours at room temperature.  
Cells harboring the Tel-VHML farCTD fusion protein grew at room temperature until 
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cell density had reached A[600]=0.55.  Protein expression was induced with 0.25mM 
IPTG for 16 hours at 18°C.  In both cases, cells were harvested by centrifugation and 
stored frozen at -80°C.   
Purification of Tel-KO2 and Tel-VHML protelomerase farCTDs was similar, with 
only minor exceptions.  For the Tel-KO2 farCTD, the frozen pellet from one liter of 
culture was thawed and suspended in 20 ml of lysis buffer containing 25% (w/v) sucrose, 
50 mM Tris–HCl (pH 8.0), supplemented with protease inhibitors (0.13 mM benzamidine 
and 0.6 mM phenylmethylsulfonyl fluoride (PMSF)), 25 mM β-mercaptoethanol (BME), 
and 1mg/ml lysozyme (Sigma).  The resulting lysate suspension, containing 0.6 mg of 
cell pellet/ml, was incubated at 0°C for approximately 30 minutes. Following sonication 
(4 X 20 seconds with a micro-probe), the suspension was treated with RNase (150 µg/ml) 
and DNase (5 µg/ml in 5 mM Mg2SO4) at 0°C for one hour.  The following were then 
added to reach the noted concentration before an overnight incubation at 0°C:  Thesit 
(Boehringer Mannheim) 0.6% (v/v), NaCl (2 M), benzamidine (0.13 mM) and PMSF 
(0.625 mM.) The suspension was clarified by centrifugation (25,000 rpm and 4°C in an 
SW40 rotor) to remove cell debris.  
Soluble protein was purified by nickel sepharose chromatography (Amersham 
Pharmacia) as follows:  clarified lysate was applied (as two batches) to a 12–15 ml 
column of Ni-NTA agarose (Qiagen) equilibrated with a buffer consisting of 10% (v/v) 
glycerol, 50 mM Tris–HCl (pH 7.5), 10 mM BME, and 0.1 mM benzamidine.  The 
protein-loaded column was then washed with 10 column-volumes of equilibration buffer 
which had been supplemented with 500 mM NaCl and 20 mM imidazole. The protein 
was then eluted from the column with equilibration buffer supplemented with 500 mM 
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NaCl and 800 mM imidazole. Following elution, fractions containing the protein were 
pooled and successively diluted and reconcentrated using 10,000 MWCO Amicon® 
Centricon® Centrifugal Filter Devices (Millipore) to remove excess NaCl and imidazole, 
reaching a final buffer concentration of 100mM NaCl  and 50mM imidazole in 50mM 
sodium phosphate, pH 7.4.  The 6x His tag was removed using biotinylated thrombin, and 
NaCl was added to reach 250µM.  The cleavage reaction mixture was then purified first 
with a streptavidin column to remove the protease, and then a nickel column to remove 
the cleaved tag as well as any uncleaved protein.  Recovery was nearly 100%, as 
indicated by Bradford assay (using Pentax BSA as standard.)  Recovered protein was 
concentrated using a fresh 10,000 MWCO centricon (Millipore), with successive 
dilutions with NMR buffer followed by concentration to a final buffer composition of 
25mM sodium phosphate, pH6.4, 10mM NaCl in 90% H2O and 10% D2O.  Final protein 
yield, as indicated by Bradford assay, was 0.350mL of 1.0mM protein.   
The purification of the Tel-VHML farCTD was similar, with the following 
differences:  the concentration of protease inhibitors originally added to the lysis buffer 
were 0.15mM benzamidine, 0.75 mM PMSF; following nuclease digestion, protease 
inhibitors were supplemented to reach original concentration and the detergent and 
sodium chloride were added to reach final concentrations of 0.25% Thesit (Boehringer 
Mannheim) and 2.5M NaCl.  Column purification differed as follows: following lysate 
centrifugation, the clarified supernatant was diluted with 50mM Tris, pH 7.4 to a total 
salt concentration of 1M NaCl, and imidazole was added to 10mM before loading onto a 
nickel sepharose column.  The column was washed first with 50mM Tris, pH7.4, 0.5M 
NaCl then with a low concentration imidazole wash (as before, but containing also 20mM 
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imidazole) before elution with 0.8 M imidazole in 50mM sodium phosphate, pH 7.4 with 
0.5M NaCl.  Pooled fractions were concentrated using a 3000MWCO Amicon® 
Centricon® Centrifugal Filter Device (Millipore).  Final protein yield, as indicated by 
Bradford assay, was 0.450mL of 1.0mM protein.  
 
NMR spectroscopy:  data collection and resonance assignments 
NMR spectra were recorded on either a Varian Inova 500 MHz or 600 MHz NMR 






N probe (cryogenic probe, 
600MHz; room temperature probe, 500MHz) and z-axis pulsed-field gradients.  To 
optimize resolution and minimize broadening, Tel-KO2 experiments were conducted at 
30°C.  Tel-VHML experiments were conducted at 25°C.  NMR data were processed 
using FELIX 2004 software (Felix NMR, Inc., Accelrys, San Diego), and the SPARKY 
software program (T.D. Goddard and D. G. Kneller, University of California, San 
Francisco) was used to assign resonances using standard approaches with tools developed 
within this program. Assignment of main-chain atoms, β carbons, and β protons was 
accomplished from analysis of triple resonance experiments including CBCACONH(3D), 
HNCACB(3D), HBHACONH(3D), and HNHA(3D)(66).  Aliphatic side-chain atoms 
beyond the β position were assigned  from resonances in additional spectra, including 
CCONH(3D), HCCONH(3D), HCCH TOCSY(3D), and HCCH COSY(3D).  Aromatic 
side-chain assignments were made using CBHD, CBHE, CHSQCTOCSY, and 
CTHMQCTOCSY(3D) experiments.  Side-chain amide resonances were assigned from 
intraresidue NOEs and HNCACB and CBCACONH spectra.  The backbone torsion angle 
restraints were derived from chemical shift information as evaluated by the TALOS 














H] NOESY experiments.   
 
Structure calculations 
Following resonance assignment of backbone and side-chain atoms, the tools in 
the SPARKY software program were used to identify NOE correlations and intensities 
from relevant NOESY spectra.  Using the resulting NOE correlation data and torsion 
angle restraints generated as described above, NOE assignments and initial structures 
calculations were generated using the automated NOE assignment and torsion angle 
dynamics capabilities of the CYANA software program (version 2.1) (68).  Briefly, using 
the criteria of chemical shift agreement, network anchoring, and consistency with an 
initial structure, a total of 100 randomized conformers were “folded” into 3D structures 
by introducing NOE constraints in a step-wise manner.  Each conformer underwent seven 
cycles, with 10,000 steps of torsion angle dynamics per cycle.  The lowest energy 
CYANA calculated structured were further refined in XPLOR-NIH using a simulated 
annealing protocol that utilizes the hydrogen bond restraints and assignments determined 
by the CYANA program.  PROCHECK-NMR (69) and the validation programs supplied 
at the PDB deposition site (http://deposit.pdb.org/adit/) were used to substantiate the 
structures.  PDB files will be deposited into the PDB database prior to publication. 
Structures were visualized and figures created using PyMOL (DeLano Scientific) (70) 
and MOLMOL (71).   
 
Use of sequence/structure databases and sequence alignment  
Structural homology searches and structural alignments were accomplished using 
the Dali and DaliLite programs (65).  Alignment of complete protelomerase sequences 
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was accomplished using CLUSTAL W (72-75).  Coordinates of  the dsRBDs of the 
DNA-binding domains of the integrase protein from conjugative transposon Tn916 (76), 
I-PpoI homing endonuclease (77), AtERF1 protein (78),  and lambda integrase(60), and 
of the dsRBDs of Xenopus  laevis XlrbpA dsRBD2 (79), Drosophila staufen dsRBD3 
(80), Aquifex aeolicus RNase III (81) used in structure comparison calculations were 
obtained from the Protein Data Bank (PDB).   
 
Results and discussion 
Identification of the structured portion of theTel-KO2 far  
C-terminal region 
NMR was used to evaluate the suitability of the construct for structure 
determination, and to design the size and conditions of the construct for study.  The 
length of the initial Tel-KO2 farCTD construct (residues 530-640 in the context of the 
full-length protelomerase) was selected to include a short region of the amino-terminal 
region of the protelomerase that had been studied using X-ray crystallography (64).  
15
NHSQC studies of the initial farCTD construct yielded mixed results.  A small number 
of well-resolved, well-distributed peaks were dominated by a central region of strong but 
poorly resolved peaks (see Figure 2.1).  
15
NHSQC profiles with this type of pattern can 





H frequencies of backbone amides of individual amino acids 
and unfolded peptides are not significantly different.  It is the different magnetic 
environments created by a folded protein which results in altered chemical shifts for 
individual amide resonances.  Poorly resolved peaks can also indicate that multiple amide 












Figure 2.1  Analysis of the full far C-terminal domain of TelKO2 to determine suitability 
of construct for spectroscopic study.   
A)  Sequence profile showing the unusually high number of negatively charged residues.   
B)  Secondary structure prediction as generated by the PSIPRED program (82, 83).  The 
structure predicts a number of helices in the N-terminal half of the peptide, but these are 
reported with a low level of prediction confidence.   
C) 
15
NHSQC of the full far C-terminal domain.  Although a number of peaks are well-
dispersed and well-resolved, the central portion of the spectrum (bordered by a dashed 
box) contains a group of peaks with poor dispersion and resolution. 
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A  Alanine 11 
R  Arginine 3 
N  Asparagine 4 
D  Aspartate 15 
C  Cysteine 0 
Q  Glutamine 2 
E  Glutamate 22 
G  Glycine 10 
H  Histidine 4 
I  Isoleucine 2 
L  Leucine 5 
K  Lysine 4 
M  Methionine 4 
F  Phenylalanine 4 
P  Proline 5 
S  Serine 5 
T  Threonine 2 
Y  Tyrosine 3 
V  Valine 6 

































Pred:  predicted secondary structure 
AA: target sequence 
Confidence of prediction confidence of prediction Conf: 
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unique compositional profile, being composed of a large number of negatively charged 
residues.  Because of proportionately large number of similar amino acids (the 
composition of the protein construct is approximately 20% glutamate and 14% aspartate 
by residue type) and because the secondary structure analysis predicted a number of α-
helices (see Figure 2.1), it was unclear based on 
15
NHSQC studies alone whether the 
poorly resolved central peaks were indicative of a partly or poorly folded protein, or 
whether the region of low resolution was a result of the unique construct profile.  
HNNOE experiments were used to indicate whether the construct was likely to be well-




N heteronuclear NOE (HNNOE) experiment can be used as a probe in 
determining the structural state of a protein.  Alone, HNNOE data is not sufficient to 
completely characterize molecular dynamics, but provides a qualitative indication of the 
mobility of individual amide bond vectors.  As such, it can provide a useful assessment 
for which residues within a polypeptide are structured and which are not (84, 85).  
HNNOE experiments indicated that while the central, largely unresolved grouping of the 
15
NHSQC resonances were from residues undergoing rapid motions characteristic of an 
unstructured polypeptide, the resolved frequencies had values that indicated that the 
residues were relatively immobile, characteristic of residues within a well-folded 
structure.  These results were supported by the predicted secondary structure calculations 
and by initial backbone assignments (vide infra.)   





C-labelled protein was purified, and resonances were assigned using a 
variety of standard triple-resonance experiments.  Unstructured protein regions typically 
yield very strong peaks, and these peaks dominated the spectra of all NMR experiments.  
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Thus, although many of the resolved peaks on the 
15
NHSQC could be assigned, the 
obfuscation of the peaks within triple-resonance spectra by the overpowering resonances 
from the unstructured protein regions prevented a complete structure determination of 
this construct.  The analysis did, however, result in an identification and mapping of the 
folded regions of the protein, which were localized to the extreme carboxy-terminal side 





HNNOE profiles and the construct residues that were assigned.   
Based on identification of the folded portion of the far C-terminal region along 
with the secondary structure prediction analysis, constructs with increasing amino-
terminal truncation were designed.  The encoded proteins were expressed and purified, 
and their 
15
NHSQC profiles were compared to determine the optimal construct length for 
structure determination.  The construct selected for structure determination, consisting of 
residues 581-640, was still predicted to contain an N-terminal unstructured region, but 
was selected nevertheless due to its better purification efficiency.  The resulting purified 
protein also contained an additional four amino-terminal residues (G-S-H-M), resulting 
from the thrombin cleavage site engineered to facilitate purification. 
Analysis of the 
15
NHSQC of the resulting construct showed fewer resonances 
than expected, as well as a range of peak widths with broadening for some individual 
peaks.  Sedimentation equilibrium studies of the first KO2 protelomerase farCTD 
construct (residues 530-640) had shown a possible multimeric equilibrium (data not 
shown) so a series of solution and experimental conditions were evaluated by NMR to 
define the optimal conditions for structure determination.  Sample conditions were varied 








Figure 2.2  Determination of structured regions of Tel-KO2 (530-640).   
A) 
15
NHSQC of the full far C-terminal domain.  Although a number of peaks are well-
dispersed and well-resolved, the central portion of the spectrum (bordered by a dashed 
box) contains a group of peaks with poor dispersion and resolution.   
B)  
15
N-HNNOE of full-length C-terminal region of Tel-KO2 (530-640).  Red 
corresponds to positive peaks, and green corresponds to negative peaks.  The 
15
N-
HNNOE indicates that the majority of the peaks in the central region of the spectrum 
belong to residues with a molecular motion similar to individual amino acids, and are 
most likely contained in an unstructured region of the peptide, while the well-dispersed 
peaks belong to residues that are in a structured region.   
C)  Sequence of TelKO2 (530-640) indicating residues for which amide resonances were 
assigned using a standard suite of triple resonance experiments.  All residues with 
assigned amides (indicated by bold, underlined text) are located in the far C-terminal end 
of the peptide.   
D)  
15
NHSQC of the selected N-terminally truncated construct.  The majority of the 
resonances representing amides in unstructured regions have been removed, while the 
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The sample temperature and NMR field strength (500 and 600 MHz) were also varied 
since these affect spectral appearance in the presence of exchange.   While the overall 
pattern of the 
15
NHSQC was maintained, different conditions resulted in a surprising 
variability of the resolution of peaks in different regions of the spectrum.  Because it was 
believed that higher temperatures and lower protein concentration would most likely shift 
the monomer/multimer equilibrium toward the monomeric form, conditions were selected 
which mimicked the 
15
NHSQC pattern changes produced under these relative conditions.  
Lower experimental temperatures are usually better for sample stability, and can also 
protect the sample from rapid solvent exchange at exposed regions, which would 
interfere with the detection of amide resonances.  Additionally, higher protein 
concentrations generally facilitate structure analysis because of better NMR signal to 
noise ratio.  Conditions were selected which created a pattern that mimicked that 
observed at higher temperatures and lower concentrations without resorting to those 
extremes for experimental conditions.   
Although the majority of the resonances were assigned and the structure 
determined, several expected resonances were unaccounted for (see Table 2.1).  These 
included several resonances that were indeed present, but simply overwhelmed and 
obscured by the strong signals issuing from unfolded region of the peptide, as well as 
resonances that were presumably weakened or absent due to excessive broadening.  
Among the former were overlapping signals from residues in the unstructured region of 
the protein, including the HB* and HG* resonances of residues E582, E585, and E587.  
Among the latter were several resonances within a compact region of the protein 




Table 2.1:   
 





GLU  582   1HB/2HB, 1HG/2HG  In unstructured N-term tail 
GLU  585   1HB/2HB, 1HG/2HG  In unstructured N-term tail 
GLU  587   1HB/2HB, 1HG/2HG  In unstructured N-term tail 
LYS  589   1HG, 1HE/2HE In unstructured N-term tail 
LYS  593   1HG/2HG, 1HE/2HE Beginning of structured region 
LYS  597   1HB/2HB  
PHE  611   H, HZ  
PHE  613   HZ  
ARG  616   HA, 1HB/2HB, 1HG/2HG, 
1HD/2HD 
Region of third β-strand 
HIS  617   H, HA, HD2 Region of third β-strand 
TYR  618   H, HA, HE1/HE2 Region of third β-strand 
ALA  619   HA Region of third β-strand 
TRP  620   H, HD1 Region of third β-strand 
GLY  622   H Region of third β-strand 
PHE  639   HZ  
29 missing chemical shift assignments.  Assignment completeness 90.5%. 






intermediate exchange rather than solvent exchange, especially given the high proportion 
of missing HA resonances (four out of five residues in this region) which are not 
typically subject to solvent exchange-based signal attenuation.  Given previous data 
suggesting a possible multimeric equilibrium of the far C-terminal region, it may be that 
this portion of the protein is the site of multimer interaction.  Additionally, the structure 
shows that this region contains an unusually high number of phenylalanines and 
tyrosines, which may have contributed to signal attenuation due to ring-flipping motions 
about the Cβ-Cγ bond axis. 
 Several amide resonances within the 616-620 region were absent from the 
15
NHSQC.  Traditional molecular graphics programs such as PyMOL (70) and 
MOLMOL (71) use the Kabsch-Sanders algorithm (86) to determine secondary structure 
elements, which essentially looks for specific hydrogen bonding patterns involving amide 
resonances.  Due to the missing amide resonances in this region, secondary structure was 
not determined in these programs.  However, analysis of solved structures has lead to the 
observation that the existence of secondary structure leads to a characteristic observable 
shift of Cα, Cβ and Cγ resonances compared to those observed for residues in random 
coil conformation (87).  The values of these shifts indicate a propensity for regions of the 
structures to populate extended or α-helical conformations.  Typically, Cα shifts are 
better predictors of alpha helical regions, while Cβ and Cγ shifts are better indicators of 
β-strand or extended conformation.  A consensus of the assigned Cα, Cβ, and Cγ shifts 
for the residues in this region show that this region, although underdetermined, is most 
likely composed of β-strand/extended region (data not shown.)  In the case of the residues 
with missing 
15
NHSQC amide resonances, other intraresidue frequencies were observable 
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and assigned from other data sets, such as the side-chain frequencies from the aromatic or 
aliphatic region of CHSQC experiments.  In no case were all resonances for a given 
residue missing or unobservable.  Nevertheless, due to the missing resonances, the 
structure is unavoidably somewhat underdetermined, particularly in the 616-620 region.   
To verify the structure and to identify themes of conservation among phage 
protelomerases, a homologous phage protelomerase far C-terminal region was selected 
for structural study.  A sequence comparison of known phage protelomerases revealed 
that the protelomerase of phage VHML (Vibrio Harvey Myovirus Like) of the free-living 
aquatic V. harveyi proteobacterium was the most distant relative of TelKO2 within the 
phage clade, so this protelomerase was selected.  Sequence conservation of the two 
regions was low (16.4%, with only 9.8% identity and 6.6% homology) as determined by 
BLAST comparisons (88, 89).  Secondary structure prediction for the two domains was 
similar, however, with two contiguous β-strands followed by a carboxy-proximal α-helix.  
The VHML far C-terminal region contains fewer phenylalanines and tyrosines, and early 
tests indicated that the VHML construct designed to be homologous to the Tel-KO2 far 
C-terminal region did not appear to have an unstructured region or suffer from issues of 
peak broadening or signal attenuation caused by intermediate exchange or other local 
dynamics, making it a good candidate for structure determination.   
 
Structure of Tel-KO2 and Tel-VHML far C-terminal domains 
The 2D homonuclear and 3D 13C- and 15N-edited NOESY experiments provided 
625 and 1098 conformationally restrictive NOE distance restraints for Tel-KO2 and Tel-
VHML far C-terminal regions, respectively.  The NMR structure ensembles have a root 
mean square deviation of 0.51Å (Tel-KO2 farCTD) and 0.43Å (Tel-VHML farCTD) for 
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backbone atoms in structured regions.  All prolines were in the trans conformation, as 
confirmed by 13Cβ and 13Cγ chemical shifts typical of trans-Prolines as part of the 
CYANA program (version 2.1) (68).  A full summary of structural statistics is given in 
Table 2.2.  Both the Tel-KO2 and Tel-VHML far C-terminal regions are well within 
acceptable ranges in all points of measure: on the basis of agreement between individual 
structures within ensembles, good geometries, low residual target function energies, and 
lack of NOE violations, the structures of both constructs are well-determined.  However, 
the Tel-VHML far C-terminal region, which was not hampered by the broadening issues 
of local dynamics or intermediate exchange as the Tel-KO2 structure was, is better 
defined, and it verifies and improves on the Tel-KO2 structure.  Compared with the 29 
missing or unassigned resonances for the Tel-KO2 construct, the Tel-VHML construct 
has only two unassigned resonances (tyrosine 57 HD1/HD2 and methionine 64 
1HE/2HE/3HE)  The Tel-VHML structure has more assigned and fewer unassigned 
NOESY peaks than its Tel-KO2 counterpart, a lower average RMSD to mean 
coordinates, and more favorable Ramachandran statistics.  This is most likely due to the 
absence of the N-terminal unstructured region in the Tel-VHML construct and better 
determination of the C-terminal region due to a lack of exchange-based broadened NMR 
signals that confounded the Tel-KO2 study.  As with the Tel-KO2 construct, a consensus 
of Tel-VHML Cα, Cβ, and Cγ shifts predicts three β-strands before the C-terminal α-
helix.  For the Tel-VHML construct, however, and all expected peaks were accounted for 
in the region of the third predicted β-strand.  The resulting structure confirms the 
presence of the third β-strand, and by homology, verifies that the Tel-KO2 construct also 




Comparison of structural statistics of Tel-KO2 and Tel-VHML farCTD structures 
 
Parameter  value 
Structure  Tel-VHML  Tel-KO2  
Residues  449-509 581-640 
    
Constraints used for structure calculation    
  Short-range NOEs |i-j|≤1   1554 934 
  Medium-range NOEs 1<|i-j|<5   208 137 
  Long-range NOEs |i-j|≥5   416 288 
  Dihedral angle constraints
a
  90 82 
  Hydrogen bonds
b 
 24 14 
    
Average Deviations from idealized geometry 
(RMSD(dev)) from XPLOR
c
    
  Bonds (Ǻ)  .002(.000) .003(.000) 
  Angles (˚)  .435(.003) .441(.004) 
  Impropers (˚)   .278(.012) .259(.009) 
    
Average     
  CYANA assignments/constraint (CYANA)  1 1 
  CYANA target function value, Å
2 
  0.29 0.02 
  Average RMSD to mean coordinates
d
:   res: 452-509 res: 593-640 
    Avg. backbone to mean (Å)  0.43 0.51 
    Avg. heavy atom to mean (Å)   1 1.03 
RMSD from ideal geometry
z
    
  Bond lengths (Å)  0.012 0.012 
  Bond angles (˚)  1.5 1.4 
    
Ramachandran analysis for structured regions
e
:  procheck procheck 
  Most favored regions (%)  96.6 92.3 
  Allowed regions (%)  3.4 7.7 
  Generously allowed regions (%)  0 0 
  Disallowed regions (%)  0 0 
    
a
Dihedral angle constraints generated using TALOS (67). 
b
Determined from an agreement of structures resulting from initial CYANA calculations (68)
 
c




Average of the 20 best-energy structures calculated using the program XPLOR using upper limit 
distance constraints and H bonds from CYANA and dihedral angle constraints from TALOS 
e
Determined using PROCHECK-NMR (69) 
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adopt the same fold, a compact domain with a βββα topology in which the three β-strands 
form an anti-parallel β-sheet which packs against and folds around the C-terminal alpha 
helix.  The structures have been called the far C-terminal domains (farCTDs.)  The solved 
Tel-KO2 and Tel-VHML farCTD structures are each represented by an ensemble of the 
20 lowest energy conformers in Figure 2.3).   
Although the farCTDs from the KO2 and VHML protelomerases belong to the 
same fold, they are nonidentical.  The two domains share only limited sequence identity 
and differ with respect to the length and curvature of the helix.  The C-terminal helix in 
the Tel-KO2 farCTD consists of 13 residues, while the helix in the Tel-VHML farCTD 
consists of 18 residues.  The N-terminal region of the Tel-KO2 farCTD appears to be 
completely unstructured, while the N-terminal region of the Tel-VHML farCTD is 
structured and somewhat extended, but does not appear to conform to common secondary 
structural elements.  The relevance of this extended region has yet to be established. 
The hydrophobic cores of the two proteins are also different.  As shown in Figure 
2.4, there are more aromatic residues in the Tel-KO2 farCTD core, especially near the C-
terminal side of the helix.  The aromatic residues appear to be stacked and angled in a 
way that would enhance the stability of the folded structure.  In particular, the 
W635/F639 and F596/F610 pairs are stacked in a nearly perfectly planar conformation in 
all five of the best-energy structures, with average distances of slightly less than 5Å 
between their centroids.  F613 is approximately perpendicular to the W635/F639 pair, 
which would also provide additional stability to the stacked pair (see Figure 2.4.)  In the 
Tel-VHML farCTD structure, only three residues (W455/W483/Y502) are involved in 













Figure 2.3  NMR ensembles of Tel-KO2 and Tel-VHML farCTD structures 
NMR ensembles of the 20 lowest-energy structures of Tel-KO2 farCTD (A) and Tel-
VHML farCTD (C) shown as backbone diagram in stereo.   NMR ensembles showing 
ribbon representation of the five lowest energy structures of the Tel-KO2 farCTD ((B), 

























Figure 2.4  Comparison of the hydrophobic cores of the Tel-VHML and Tel-KO2 
farCTDs.   
A)  Ribbon diagrams of the top five structures of the Tel-VHML farCTDs.  The 
hydrophobic residues which make up the interior are shown as sticks.  Aliphatic residues 
are colored wheat while aromatic residues are shown in white.   
B)  The aromatic stacking network of the Tel-VHMLfarCTD.  The ten best energy 
structures are shown, and are represented as ribbon diagrams of the backbone.  The side-
chains of relevant residues are shown as sticks.  Residues W455 (yellow), W483 (green), 
and Y502 (blue) are oriented in an orthogonal conformation to each other. 
C)  Ribbon diagrams of the top five structures of the Tel-KO2 farCTD.  The hydrophobic 
residues which make up the interior are shown as sticks.  Aliphatic residues are colored 
pale blue, while aromatic residues are shown in white.   
D)  The aromatic stacking network of the Tel-KO2 farCTD.  The ten best energy 
structures are shown, and are represented as ribbon diagrams of the backbone.  The side-
chains of relevant residues are shown as sticks.  The W635/F639 stacking pair is shown 
in red.  F613, which is orthogonal to this pair, is shown in yellow.  The F596/F611 pair is 
shown in green.  
The interior of the Tel-KO2 farCTD contains more aromatic residues, with an extensive 
network of stacking interactions both planar and perpendicular.   
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A.                                                   B.  







C.                                                    D. 
 
 
W635/F639 stacking pair (red) 
perpendicular to F613 (yellow).  
F596/F611 stacking pair (green) 
W455 (yellow), W483 (green), 
and Y502 (blue) in orthogonal 






orthogonal conformations to each other.  The Tel-VHML farCTD appears to be 
additionally stabilized by the interaction of the C-terminus of the longer helix with the 
somewhat extended N-terminal region.  The homologous Tel-KO2 farCTD N-terminal 
region lacks observable structure.   
Because of the very limited sequence conservation, differing secondary structure 
predictions, and the varying length of unstructured linker regions between the farCTDs 
and their N-terminal protelomerase regions, automated sequence alignment programs 
have difficulty in recognizing the conserved domain as being homologous among 
protelomerases.  Most prediction programs predict two, rather than three β-strands, some 
identifying strands β2β3 (as with Tel-KO2 farCTD) and some identifying strands β1β2 
(as with Tel-VHML farCTD) which further complicates alignment (see Appendix A for a  
comparison of Tel-KO2 and Tel-VHML secondary structure prediction and comparative 
Cα shifts.)  Having solved the Tel-VHML and Tel-KO2 farCTD structures, we used the 
DaliLite program to overlay the structures, and identified several conserved and similar 
residues (65).  The hydrophobic interior of the two proteins was especially well-
conserved, resulting in a positionally homologous network of hydrophobic residues (both 
aromatic and aliphatic) that is shown in Figure 2.5.   
Aside from the hydrophobic core, the structural overlay revealed additional 
regions of sequence similarity which appear to be conserved among the other phage 
protelomerases (see Figure 2.6).  The loop between the β1β2 strands, for instance, 
consists of a GD-rich region which is highly conserved among the other putative 
protelomerase farCTDs.  The loop between the β2β3 strands is shorter than the β1β2 
loop, and contains a conserved glycine.  The short loop between the β3 strand and the  
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Figure 2.5  Conserved network of hydrophobic residues in the interior of phage 
protelomerase farCTDs.   
A)  Cartoon showing an overlay of the solved farCTDs.  The Tel-KO2 farCTD is shown 
in cyan, and the Tel-VHML farCTD is shown in red.  Hydrophobic residues that are 
conserved by type and location are represented as sticks.  Figure text denotes the 
comparative residues with (V) indicating that a residue belongs to Tel-VHML and (K) 
indicating a Tel-KO2 residue.  The two structures have an RMSD of 2.1 in comparative 
regions as calculated by a DaliLite structure comparison (65). 
B)  A sequence alignment of the two domains indicates the location of the similarly 
conserved residues.  A consensus sequence is shown beneath the alignment, in which (%) 
indicates an aromatic residue and (h) represents a hydrophobic residue (either aromatic or 
aliphatic).  The symbols above the sequence alignment indicate the location of the 
secondary structure elements identified by structure determination (β indicates β-strand 
or extended conformation, while α indicates α-helix).  An arrow indicates the first residue 
within the sequences for which DaliLite structure comparisons were calculated.  
  
                         βββββββ      ββββββ   ββββββββ   ααααααααααααααααααα 
                         >>>>>>>      >>>>>>   >>>>>>>>   OOOOOOOOOOOOOOOOOOO 
Tel-VHML    DQKVSWPKAKDIKVQ-SKKEGD-MWHVWTEVNGMRWENW-SKGRKTEAVKALRQQYERESAEM 
Tel-KO2  AEVAEQEEKHPGK-PNFKAPRDNGDGTYMVEFEFGGRHYAWSGAAGNRVEAMQSAWSAYFK 
                         |          | |   |                ||  |            









stacking pair (red) 
is perpendicular to 
F613 (yellow) 
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Figure 2.6  Conserved residues of the phage far C-terminal domain. 
A) and B)  Structural overlay showing the externally-facing residues which are conserved 
according to position and type.  The overlaid backbones of Tel-VHML and Tel-KO2 are 
shown in red and cyan, respectively.  Views A) and B) are shown with a 90° vertical 
rotation to each other.  Text indicates the identity and sequence number of residues in the 
context of the full-length protelomerase, with (V) indicating the residue belongs to Tel-
VHML and (K) indicating the residue belongs to Tel-KO2.   
C)  An alignment of all known and putative phage protelomerase farCTDs as compared 
to the solved Tel-KO2 and Tel-VHML structures. The numbers to the right of each 
aligned sequence indicate the C-most residue of that sequence in context of the full-
length protelomerases.  Residues which appear to be conserved through a majority of the 
protelomerases are shown in red and underlined, and are numbered in both the aligned 
sequences and the displayed overlays (1-11). Underneath the alignment is displayed:  
first, an indication of the degree of conservation among the domains; next, a consensus 
sequence; and finally, the location of the conserved residues within the aligned Tel-
VHML and Tel-KO2 structures.  Symbols indicating consensus sequence, conservation, 
and structural position are as follows:   
For the consensus sequence: 
h:  hydrophobic (either aliphatic or aromatic)  
u:  small (Gly, Ala) 
%:  aromatic 
^:  polar/charged 
±:  charged 
+:  positively charged 
„:  negatively charged 
 
For the degree of conservation: 
*   total conservation 
:   high conservation 
.   moderate conservation 
 
For the location of the conserved residues:  
i:  the side-chain extends into the interior of the protein 
α:  the side-chain extends externally from the face of alpha helix 
e:  the side-chain extends externally from the face of the beta sheet 
l:  the residue resides in a loop region 
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                  1    2   3  45       6  7          8    9  10  11            
        ---------------βββββββ------βββββββ----ββββββ-----ααααααααααααααααααα    
 VHML QEEDQKVSWPKAKDIKVQ--SKKEGD-MWHVWTEVNGMRWEN-WS-KGR-KTEAVKALRQQYERESAEM  509 
 KO2  AEVAEQEEKHPGK-PNFKA-PRDNGDGTYMVEFEFGGRHYAW-SGAAGN-RVEAMQSAWSAYFK       640 
 N15  EEGPEEHQPTALK-PVFKP-AKNNGDGTYKIEFEYDGKHYAW-SGP-ADSPMAAMRSAWETYYS       631  
 PY54 SDNASDEDKPEDK-PRFAAPIRRSED-SWLIKFEFAGKQYSW-EG-NAESVIDAMKQAWTENME       628  
 VP882VPAAEKQPKKAQK-PRLVAH-QV-DDEHWEAWALVEGEEVAR-VKIKG-TRVEAMTAAWEASQKALDD   538 
 Halm VAAAVPKEVAEAK-PRLNAHPQ--GDGRWVGVASINGVEVAR-VGNQAG-RIEAMKAAYKAAGGR      520 
 VCampVVETKPKDETVIK-PKMKGH-KE-DDGTWLVDVTIEDKSWQISVGKEPKNVMDAFKLAWNEFvyrkalpe…… 
 Conservation:    * :....  :  .*. : . . . :  .       :   ..*:. ::.  .            
 Consensus:       K-P^h^u--+^-GDG-%-h-h-h-G--%-------u^--h’Ah+-A%^-%-------      







































alpha helix is also composed of small residues.  The external face of the alpha helix 
shows considerable conservation according to residue type.  When viewed through the 
helix, a series of charged and polar residues align in a surprisingly linear fashion, 
especially given the variability in the curvature of the helix.  Judging from the aligned 
putative protelomerase farCTDs, this pattern is nearly universally conserved, and 
includes, starting from the N-terminal base of the helix, a small residue, a negatively 
charged residue, and two successive polar/charged residues.  Perhaps equally notable as 
the conservation within the loops and on the face of the alpha helix is the complete lack 
of conservation on the external face of the β-sheet.  There is, however, notable 
conservation at the beginning and end of strand β1, which consists of basic or polar 
residues, as well as a universally conserved lysine just prior to the start of the same 
strand.   
The calculated electrostatic surface potentials of the Tel-KO2 and Tel-VHML 
structures are very similar, as calculated by the Adaptive Poisson-Boltzmann Solver 
(APBS) add-in within the PyMOL program (70, 90).  Both structures display a positive 
surface along the β1/helix face, and a negative surface along the β2/helix face.  The 
calculated surface potentials of these faces are shown for both proteins in Figure 2.7.   
With the structure of the farCTD solved and regions of conservation identified by 
structural and sequential alignment, an understanding of the functionality of this domain 
will be aided by the identification of its binding partner.  Initial studies aimed at 
accomplishing this directive both by surface plasmon resonance and NMR were 
inconclusive.  However, a careful comparative analysis of the farCTD with the sequence 








Figure 2.7  Electrostatic Surfaces of the Tel-KO2 and Tel-VHML farCTDs show 
similarly charged surfaces along homologous faces..   
Red indicates a negative charge, while blue indicates a postitive charge.  White indicates 
a neutral charge.  The surfaces are generated at partial transparency to show the 
secondary structure cartoon beneath.  The cartoon is colored in a spectrum with the N-
terminus beginning in blue and the C-terminus finishing in red.   
A.  Tel-KO2 farCTD oriented to show the most negatively charged surface, along the 
β3/helix face.   
B.  Tel-KO2 farCTD oriented to show the most positively charged surface, along the 
β1/helix face.    
C.  Tel-VHML farCTD oriented to show the most negatively charged surface, along the 
β3/helix face.   
D.  Tel-VHML farCTD oriented to show the most positively charged surface, along the 
β1/helix face.  
 The two views of each protein are rotated approximately 180˚ relative to each other 
along the horizontal axis.   
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class of binding partner of the farCTD, which will facilitate the design of future studies.   
A Dali structure search revealed that the protelomerase farCTD structures most 
closely resemble a fold known as the double-stranded RNA-binding domain (dsRBD), 
the founding member of the double-stranded RNA-binding domain-like superfamily (91).  
The dsRBD-like superfamily also consists of the homologous–pairing domain of Rad52 
recombinase and the ribosomal S5 protein, N-terminal domain.  The structural statistics 
of the protelomerase farCTDs compare favorably with those of other recently published 
dsRBDs (92).  Proteins which contain dsRBDs can be separated into classes based on 
their known binding partners.  dsRBDs are known to bind RNA, DNA, and other 
proteins.  An analysis of the conserved features of each class of dsRBD will help to 
indicate which macromolecular class is the likely partner of the protelomerases farCTD, 
and will aid in the design of future studies.   
 
The double-stranded RNA binding domain 
The classic dsRBD is an αβββα fold in which an anti-parallel three-stranded β-
sheet packs against a carboxy-proximal α-helix and is further stabilized by an additional 
amino-proximal α-helix.  The dsRBD was identified in 1992 by St. Johnston et al., who 
noted repeated regions of sequence similarity in the Drosophila melanogaster gene, 
staufen, and a Xenopus laevis gene of then unknown function (93).  The group used the 
repeats in both systems to identify a minimum consensus sequence, which they used to 
search the protein sequence database.  In addition to the repeats in staufen (required for 
the localization of maternal mRNAs) and the X. laevis gene, the product of which was 
later named Xlrbpa, (for Xenopus laevis RNA-binding protein A, a homolog of human 
TRBP involved in formation of the RISC complex) additional proteins containing the 
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consensus sequence were identified, several of which were known or thought to bind 
double-stranded RNA.  These included human dsRNA-activated inhibitor (DAI), human 
trans-activating region (TAR) binding protein (TRBP), and RNase III.  The thousands of 
examples of this domain that have since been identified are from widely diverse origins 
ranging from archaea, bacteria, and viruses to eukaryotes, in which they are found in both 
the nucleus and cytoplasm of both plants and animals.  Although all dsRBDs share a 
structural fold, dsRBDs that bind different classes of macromolecules have distinct 
characteristics that reflect their different modes of macromolecular recognition.  Based on 
principles of sequence conservation, general architecture, and hierarchy of important 
observed binding regions between the farCTD and other dsRBDs, it is most likely that 
the farCTD binds DNA.  However, it is possible that the domain may also interact with 
other protein elements, either of protelomerase or other origin.   
 
dsRBD as RNA-binder 
As the eponymous and founding member of the superfamily, RNA-binding 
dsRBDs define the classical architectural fold (αβββα) and preferentially bind dsRNA 
over dsDNA and RNA/DNA hybrids.  Sequence conservation has been extensively 
studied and is well characterized (see Figure 2.8).  It extends across all four elements of 
secondary structure and in the β1β2 and β3α2 loops, and is especially high in the three 
regions involved in direct RNA interaction (94).  Classifications of dsRBDs have been 
made in terms of sequence, the number of copies of dsRBDs within the dsRBD-
containing protein, the presence of other intraprotein domains such as a catalytic domain, 
and RNA-binding ability (95).  The five separate dsRBDs in PKR, for instance, are 
classified as to whether or not they bind dsRNA at all (dsRBDs 1, 3, and 4 do) as well as  
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Figure 2.8  Comparative consensus sequences of dsRNA-binding dsRBDs and DNA-
binding dsRBDs with known and putative protelomerase farCTDs.   
A)  The consensus sequence for RNA-binding dsRBDs derived from the sequence logo 
of the hidden Markhov model (HMM) created by Tian et al. (94).  Reprinted by 
permission from Macmillan Publishers Ltd: [NATURE REVIEWS | MOLECULAR 
CELL BIOLOGY] (Tian et al, 5, 1013-1023 (December 2004) doi:10.1038/nrm1528 
citation), copyright (2004).  The HMM was created from all dsRBDs then available in the 
InterPro database (1,428 total.)  Adjacent residues are separated by a line, the thickness 
of which indicates the probability of an insertion of random residues. The width of each 
residue indicates the probability of having a residue at that position (narrow residues tend 
to be deleted at their positions compared to wide residues.)  The height of a residue 
indicates how conserved it is among all dsRBDs. Secondary structures of the dsRBD are 
indicated above the sequence logo. The three dsRNA interaction regions (regions 1, 2 and 
3) are marked below the sequence logo. Intervening sequences between α-helices (α) and 
β-strands (β) are known as loops: loop 1 is between helix 1 and strand 1, loop 2 between 
strand 1 and strand 2, loop 3 between strand 2 and strand 3, and loop 4 between strand 3 
and helix 2.  A consensus sequence is shown below the RNA-binding dsRBD HMM, 
with residues that are also conserved among protelomerase farCTDs highlighted. 
B)  An alignment of known and putative farCTD sequences is shown, with a farCTD 
consensus sequence displayed both above and below the alignment.  Within the 
alignment, residues conserved among farCTDs are indicated in red text and underlined, 
while secondary structure (determined by solution or homology) is highlighted, and is 
indicated above the alignment:   (α, alpha helix; (β, extended or beta strand 
conformation.)  In the consensus shown above the alignment, residues conserved between 
farCTDs and RNA-binding dsRBDs are highlighted.  In the consensus sequence 
displayed below the alignment, residues conserved between DNA-binding dsRBDs are 
highlighted. 
C)  A consensus sequence and alignment of DNA-binding dsRBDs.  Secondary structure 
is indicated as described in B.  Within the β-strands, externally-facing residues are 
indicated by colored text.  Conserved residues are underlined.  The consensus sequence is 
displayed above the alignment, with residues that are also conserved among 
protelomerase farCTDs highlighted.   
All three consensus sequences contain alternating hydrophobic residues in the region of 
strand β2 which probably reflects conservation of core-stabilizing residues, as well as a 
small (glycine or proline) residue at the beginning of strand β1 (G or P) and the end of 
strand β3.  Outside of these regions, only one other residue is well-conserved between 
RNA-binding dsRBDs and protelomerase farCTDs (an alanine in the middle of the C-
terminal α-helix.)  None of the points of conservation between farCTDs and RNA-
binding dsRBDs are in the regions noted for RNA-interaction.  Outside of regions of total 
domain conservation already mentioned, similarity between the protelomerase farCTD 
and DNA-binding dsRBD consensuses is greatest just N-terminal to the beginning of and 
at the C-terminal end of the strand β1, which contain conserved positive and primarily 
positive or polar residues, respectively.  In the DNA-binding dsRBDs, these residues 




A. RNA-binding dsRBD concensus and hidden Markhov Model of 1,428 dsRBDs 
 
      
   RNA-binding dsRBD consensus sequence: 
   PK^-L^E-----+----P-Y-------GP--H-P-F-h-V-h-G/P-----G-G-SKK--AE^-AA--AL---L-- 
 
B. farCTD sequence alignment and consensus sequence 
    
   farCTD consensus sequence:  
      ------------K-P^h^u--+----GDG---%-h-h-h-G---%----G--u---h’Ah+-A%^-%------ 
      --------------βββββββββ---------βββββββ---ββββββββ----ααααααααααααααααααα  
VHML  QEEDQKVSWPKAKDIKVQ--SKKE---GD--MWHVWTEVNG-MRWEN-WSK-GR-KTEAVKALRQQYERESAEM 
KO2   AEVAEQEEKHPGK-PNFKA-PRDN--GDG--TYMVEFEFGG-RHYAW-SGAAG-NRVEAMQSAWSAYFK  
N15   EEGPEEHQPTALK-PVFKP-AKNN--GDG--TYKIEFEYDG-KHYAW-SGP-ADSPMAAMRSAWETYYS      
PY54  SDNASDEDKPEDK-PRFAAPIRRS--ED---SWLIKFEFAG-KQYSW-EG-NAESVIDAMKQAWTENME      
VP882 VPAAEKQPKKAQK-PRLVAH-QV---DDE--HWEAWALVEG-EEVAR-VKIKG-TRVEAMTAAWEASQKALDD  
Halm  VAAAVPKEVAEAK-PRLNAHPQ----GDG--RWVGVASING-VEVAR-VGNQAG-RIEAMKAAYKAAGGR    
VCamp VVETKPKDETVIK-PKMKGH-KE---DDG--TWLVDVTIED-KSWQISVGKEPKNVMDAFKLAWNEFvyrk… 
 
   farCTD consensus sequence 
        ----------K-P^h^u--+^---GDG---%-h-h-h-G---%----G--u---h’Ah+-A%^-%-------   
 
C. DNA-binding dsRBD consensus sequence and alignment: 
 
                  +-G/P----+^----G----%-h-h------G----hG------------------------- 
      -----------------βββββββ------βββββββ-------βββββββ--ααααααααααααααααααα    
1gcc   …AVTAAKGKHYR--G--VRQRPW---G---KFAAEIRDPAKNGARVWLGTFETAE-DAALAYDRAAFRMR… 
Tn9  MSEKRRDNRGRILKT-G--ESQRK---DG---RYLYKYIDSF--GEPQFV-YS… 
                                                  …WKLVATDRVPAGKRDAISLREKIAEL 
λINT     MGRRRSHERRDLPPNLYIRNN---G---YY--CYRDPRT-G-K-EFGL—GRDRRIAITEAIQANIELFS… 





Region 1 Region 2 Region 3 
α2 β3 β2 β1 
65 
which bind RNA with the greatest affinity (96, 97).   
Beyond a preference for dsRNA, the question of binding specificity by the 
dsRBD must be addressed in diverging but related aspects: RNA sequence specificity,  
RNA helix geometry specificity, and RNA “secondary structure” specificity.  Although 
most data suggests that dsRBDs do not impart binding specificity, increasing numbers of 
studies imply degrees of binding preference.  At this juncture, it is perhaps only possible 
to say that while most dsRBDs bind most dsRNA, some dsRBDs bind dsRNA more 
tightly, and do so with varying exclusivity.  Appendix B contains a literature review of 
the current understanding of the ability of dsRBDs to impart binding specificity to the 
proteins in which they are located.  
Multiple structures of dsRBDs in complex with dsRNA have revealed common 
recognition and binding patterns.  As reviewed by Tian et al., in all cases, including the 
second dsRBD in X. laevis XlrbpA with a non-physiological dsRNA  (pdb accession code 
1DI2) (79), D. melanogaster staufen dsRBD3 in complex with an RNA hairpin (pdb 
accession code 1EKZ) (80), A. Aeolicus RNaseIII dsRBD in complex with dsRNA (pdb 
accession codes 1RC7 and 1YYW)  (81), and S. cerevisiae RNase III (Rnt1p) in complex 
with the 5' terminal RNA hairpin of snR47 precursor (pdb accession code 1T41), the 
domain binds along a single face of the dsRNA (94).  Protein to RNA interactions are 
primarily to RNA phosphate and 2‟-hydroxyl groups rather than to sequence-specific 
contacts, and are often water-mediated.  Along the face of the RNA, successive minor-
major-minor grooves are contacted by protein helix α1 (2‟-hydroxyls contacted), the β3–
α2 loop (backbone phosphates contacted), and the β1–β2 loop (2‟- hydroxyls contacted) 
respectively.  Figure 2.9 shows an overlay of three dsRBDs which have been solved   
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Figure 2.9  Comparison of VHML farCTD with reported structures of RNA-binding 
dsRBDs bound to dsRNA.    
Overlay of the solved dsRBDs bound to dsRNA with Tel-VHML farCTD as calculated in 
a DaliLite structure comparison.  Xenopus laevis XlrbpA dsRBD2with a non-
physiological dsRNA (blue) (79), Drosophila staufen dsRBD3 in complex with an RNA 
hairpin (yellow) (80), Aquifex Aeolicus RNaseIII dsRBD in complex with dsRNA 
(green), and Tel-VHML farCTD (red). The structures show the common recognition 
modes as indicated.  
 
Minor groove 2, 
contacted by the 
β1-β2 loop (shorter 
in farCTDs--
VHML in red) 
Major groove 
Contacted by the 
β3–α2 loop 
Minor groove 1, 





bound to dsRNA, along with our Tel-VHML farCTD structure.   
Of the three important RNA interaction motifs of the known RNA-binding 
dsRBDs, only the third, the loop between strand β3 and helix α2, is comparatively 
structurally well-conserved in the farCTD.  Among RNA binders, however, the highly 
conserved sequence in this region consists of an SKK*AE, which is not present in the 
farCTD.  The first interaction motif, helix α1, is not present in the solved structures of the 
protelomerase farCTD.  It is possible that a helix forms in the unstructured region of the 
farCTD on binding or that it interacts with a helix from a remote region of the protein, 
but such interactions are not described for known RNA-binding dsRBDs, for which the 
secondary structural elements are always contiguous.  The second interaction motif, the 
loop between strands β1 and β2, is the site with the most variability in length for RNA 
binders, but is nevertheless usually longer than the loop observed in the protelomerase 
farCTD (94).  The RNA binding dsRBDs contain a highly conserved GP*H sequence in 
this region, which in the farCTD is substituted by a DG-rich sequence (94).  The β1β2 
turn in DNA-binding dsRBDs, on the other hand, contains a glycine but lacks other 
notable conservation. 
 
dsRBDs as protein binders 
Some dsRBDs are known to interact with protein elements, although this function 
is much less well characterized than RNA recognition.  The majority of protein-binding 
dsRBDs are grouped with RNA-binding dsRBDs, and the degree to which the domain is 
dedicated toward RNA versus protein binding is sometimes a matter of controversy, as in 
the case of the two dsRBDs of rat ADAR2 (98).  However, the dsRBDs in several 
proteins have been shown to act as dimerization domains, allowing dsRBD-containing 
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proteins to form homodimers or to dimerize with heterologous proteins which also 
contain dsRBDs (99-103).  dsRBDs have also been shown to interact with other, non-
dsRBD protein domains (104, 105).  Despite the classification of some dsRBDs as 
protein-binding domains, however, the identification of the principles behind protein 
binding has remained elusive. 
A comprehensive or definitive analysis of the characteristics of protein-binding 
dsRBDs has yet to be accomplished, either by sequence conservation or locational 
mapping on the domain.  St. Johnston originally identified two types of dsRBD based on 
level of sequence conservation (93, 106).  Type A dsRBDs maintained conservation over 
the entire length of the domain, while type B dsRBDs maintained sequence conservation 
primarily in the C-terminal region, but less so in the N-terminal sides, with only moderate 
conservation in the second RNA-interacting region (the β1β2 loop.)  While some of the 
identified type B dsRBDs (such as Xenopus XlrbpA dsRBD3 and human TRBP 
dsRBD3) have since been shown to bind protein elements, no consistent sequence 
consensus of this relatively small group has been identified, other than a comparative lack 
of conservation in N-terminal regions.  A consistent or definitive mapping of important 
protein-binding regions is also lacking.  An early study of the dsRBDs of PKR identified 
the hydrophobic residues on one side of an amphipathic helix as the dimerization site, but 
a later structure showed that this side of the helix interacted with the three-stranded β-
sheet and was buried in the protein, and the mutations (A or L to E) were probably more 
likely to compromise the entire structural fold rather than simply interrupting 
dimerization (107, 108).   
RNA-independent interaction of dsRBDs has been documented primarily by 
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biochemical means, and although a few structures showing dsRBD-protein interactions 
have been solved, more are needed before a consensus can be described.  The current 
structures provide examples showing different binding surfaces being utilized for protein 
interaction.  Although each of these structures provides only a single example of a 
protein-binding face, the interactions are worth noting as possibilities for the function of 
the protelomerase farCTD.  The first example shows the only example of a 
dsRBD/dsRBD interaction.  The structure of the human DGCR8 core, containing two 
dsRBDs and a C-terminal region (pdb accession code 2yt4), was recently determined at a 
resolution of 2.6 Å (109).  In complex with its partner Drosha, DGCR8 cleaves primary 
microRNA (pri-miRNA) substrates into precursor miRNA and initiates microRNA 
maturation.  As the structure shows, the two dsRBDs interact through the β2β3 loop of 
dsRBD1 and the C-terminal end of dsRBD2‟s helix α2 (see Figure 2.10).  Both domains 
exhibit many more interactions to a central helix, which is sandwiched between the two 
dsRBDs, primarily by the C-terminal regions of their second helices (α2).  Both dsRBDs 
also show interactions with other protein elements through one side of their first helices, 
α1.  Interestingly, the regions of the dsRBDs which show interactions to each other and to 
the sandwiched helix are different than those traditionally associated with dsRNA 
binding, which may indicate that in this case dsRNA binding and protein binding by a 
dsRBD need not be mutually exclusive.  A model showing dsRNA interaction with an 
intact DGCR8 core was proposed based on a superimposition of the DGCR8 dsRBDs 
with the Xlrbpa–dsRNA complex structure (79).  Although the dsRNA modeling is 
compelling, DGCR8 was not solved in the presence of its RNA substrate, and more data 







Figure 2.10  Crystal structure of the human DGCR8 Core showing dsRBD/protein 
contacts.   
A)  The DGCR8 core colored in spectrum with the N-terminus beginning in blue and the 
C terminus finishing in red.   
B)  The DGCR8 core showing the two dsRBDs and the central helix: dsRBD1 is colored 
green, and dsRBD2 is colored yellow.  The central helix is shown in red.  Both dsRBDs 
show interactions to the central helix with the C-terminal end of their second alpha 
helices (helix α2.)  Loop β2β3 of dsRBD1 interacts with the C terminal end of dsRBD2s 
helix α2.  The dsRBDs also make protein contacts with their first helices, α1, dsRBD1 
with β-strands from elsewhere in the core, and dsRBD2 with the central alpha helix.  
C)  The model created by Sohn et al. by superimposing the Xlrbpa–dsRNA complex 
structure onto the dsRBDs of DGCR8.  The molecule is rotated approximately 90˚ around 
a horizontal axis from the views in A) and B), and shows that the RNA-binding surfaces 
are different than those that bind protein.   
Reprinted by permission from Macmillan Publishers Ltd: [NATURE STRUCTURAL & 
MOLECULAR BIOLOGY] (Sohn, S. Y., Bae, W. J., Kim, J. J., Yeom, K. H., Kim, V. 
N., and Cho, Y. (2007) Crystal structure of human DGCR8 core, Nature structural & 
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extensive remodeling in order to act catalytically with its partner.  Nevertheless, the 
structure provides an example of protein-interacting surfaces of a dsRBD.  Proteins with 
dsRBDs are often highly modular, containing flexible or extended linkers in between 
domains which has resulted in a less complete understanding of protein binding elements.  
The family of bacterial RNase III enzymes, for example, contain an N-terminal catalytic 
domain and a C-terminal dsRBD attached by a flexible linker.  Previous crystal 
structures, such as the Mycobacterium tuberculosis RNase III, solved as a 2.1 Å 
homodimer, did not contain credible electron density for the carboxy terminal dsRBD, 
leaving the authors to speculate that the domain was highly mobile with respect to the 
nuclease domain (110).  A recent crystal structure of Aquifex aeolicus RNase III was 
solved in the presence of dsRNA and showed both the endonuclease and dsRBD engaged 
with the dsRNA, but there was no interaction between the two domains, which are 
separated by a seven residue linker (111).  The Thermotoga maritime RNase III structure, 
however, solved at 2.0 Å resolution, shows a second example of a dsRBD/protein 
interaction.  The T. maritime structure was solved as a homodimer without RNA, and 
shows an apparent interaction between the carboxy-terminal dsRBD and its amino-
terminal nuclease domain.  The T. maritime RNase III structure was deposited by the 
Center for Structural Genomics (Wilson, I.A., deposition: 2002-09-13, release: 2002-11-
13, publication forthcoming; DOI: 10.2210/pdb1o0w/pdb; pdb accession code 1O0W) 
and shows that in this case, the primary protein interacting surface of the dsRBD is the 
face of the second helix α2, which interacts with the nearly parallel helix of the 
endonuclease domain (see Figure 2.11.)  This series of structures, like the model for the 







Figure 2.11 Interactions of the dsRBD of bacterial RNase IIIs 
A) and B) show the dsRBD-endonouclease interaction of the Thermatoga maritime 
RNase dimer (pdb accession code 1O0W.)  C) and D) show the dsRBD-RNA interaction 
of the Aquifex aolicus RNase III (pdb accession code 2NUG.) 
A)  One monomer is shown in gray, while the other is colored in spectrum with the N-
terminus beginning in blue and the C terminus finishing in red.  In the spectrum-colored 
monomer, the dsRBD is on the upper left-hand side and colored in red and orange  
B)  A close-up of one monomer of the RNase III from T. maritime.  The dsRBD is 
colored in red and orange.  Extensive interactions occur between the face of the C-
terminal α-helix (red) and the nearly parallel helix of the endonuclease domain (yellow).   
C)  RNase from A. aolicus, crystallized with RNA.  The enzyme is oriented with the 
catalytic domain positioned similarly to the catalytic domain of T. maritime RNase 
shown in A), and is colored similarly, with one monomer in gray and the other shown in 
spectrum.  The dsRBD of the spectrum-colored monomer is colored in orange and red.    
The dsRBD (shown in red and orange) has obviously changed orientation (as described in 
the manuscript presenting the structures.)   
D)  The A. aolicus structure has been rotated to show that the dsRBD (red) is not bound 
to the catalytic domain (green) but the linker has allowed it to perform its expected 
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implies that a single dsRBD can bind more than one type of macromolecule. 
Despite the growing understanding of the role of dsRBDs in protein interactions, too few 
examples are known.  Further biochemical and structural analysis will be required before 
determining principles such as sequence conservation and binding patterns can be 
identified.  Thus, while the possibility of farCTD/protein interaction cannot be ruled out, 
such a functional role is also not conclusively supported by comparison to known 
structures. 
 
DNA-binding dsRBDs:  Nonclassical dsRBDs 
A small number of proteins containing a non-classical dsRBD have been recently 
reported to bind dsDNA in a novel way, and comprise a new DNA-binding fold.  The 
proteins include Arabidopsis thaliana ethylene responsive factor domain 1 (AtERF1-
DBD) (78), the amino terminal DNA-binding domain of the conjugative transposon 
Tn916 integrase (Tn916-Int-DBD) (76), and the arm-binding domain of Escherichia coli 
bacteriophage λ integrase, sometimes called the N-domain. (60). All structures were 
reported as protein/DNA complexes.  The domains present as a variation on the classical 
dsRBD in that the first helix, α1, is missing, resulting in a contiguous, anti-parallel, three-
stranded β-sheet which packs against a carboxy-proximal α-helix (βββα.)  A fourth 
protein, a homing endonuclease from the slime mold Physarum polycephalum (I-PpoI) 
(77), has been found to bind DNA in a similar way, but differs from the other structures 
in the architectural arrangement of its secondary structural elements:  the helix against 
which the three-stranded β-sheet binds is not directly carboxy-proximal to the β-strands, 
but originates instead from a noncontiguous, amino-relative location in the protein.   
For all four proteins, the DNA binding surface is the face of a β-sheet composed 
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of three contiguous, anti-parallel strands whose comparative lengths (among the proteins) 
are similar but not identical.  The β-sheet inserts into the major groove of its cognate 
DNA, where alternating residues project toward the interior of the protein or directly out 
from the face of the β-sheet where they interact site-specifically with DNA bases or with 
the phosphodiester backbone.  The dsRBD is oriented within the major groove such that 
strand β1 (N to C) is parallel to the proximal DNA backbone which is oriented in a 5‟to 
3‟ direction.  Strand β3 (N to C) is proximal to the complementary strand‟s backbone, 
which aligns 3‟ to 5‟ in a parallel manner (see Figure 2.12).  The β-sheet adopts a 
conserved curvature such that the DNA-facing side of strands β1-β2 forms a concave 
surface, while the β2-β3 DNA-facing surface is convex.  This hybrid curvature 
maximizes the DNA contacting area by molding the protein to the shape of the major 
groove.   
The location of the residues within the β-sheet that are important for base 
recognition varies among the four proteins.  A typical three-stranded β-sheet is slightly 
wider than can be easily accommodated within the DNA major groove, and the four 
proteins have different strategies to overcome that problem (112).  The Tn916-Int-DBD 
is rotated slightly within the major groove so that strands β2-β3 insert more deeply and 
contain all but one of the residues responsible for base-recognition, while strand β1 abuts 
the proximal DNA backbone and contains small externally facing residues that 
accommodate backbone proximity.  The AtERF1-DBD is also rotated slightly within the 
major groove, but in the opposite direction of the Tn916-Int-DBD, inserting strands β1-
β2 more deeply, with small residues on the C-terminal end of strand β3 to accommodate 









Figure 2.12 Comparison of VHML farCTD with reported structures of DNA-binding 
dsRBDs bound to DNA.    
Overlay of the solved DNA-binding dsRBDs bound to dsDNA with Tel-VHML farCTD 
as calculated in a DaliLite structure comparison.  1z1g:  λ-integrase arm-binding domain 
bound to accessory (arm) DNA (slate) (60); 1tn9: amino terminal DNA-binding domain 
of the Tn916 integrase protein with its dsDNA binding partner (76, 112) (magenta), 1gcc: 
Arabidopsis thaliana ethylene responsive factor domain 1 and its DNA binding partner 
(78) (lime-green); Tel-VHML farCTD (red). The structures show the common 
recognition modes as indicated.  
A)  A view showing the insertion of the β-sheets into the major groove 
B)  A view showing the similarity of the alignment of the β-strands and of the lengths of 
the intervening loops. 
C)  A view showing the orientation of the helices compared to the β-sheets.   Much more 
variation is present in helix length and orientation compared to RNA-binding dsRBDs. 
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sheet plays the main role in base-specific recognition, with three of the four externally 
facing residues making base-specific contacts, and the fourth contacting the phosphate 
backbone.  One residue in each of the first and third strands in the sheet (β3 and β5 in 
context of the full protein) also make a base-specific contact, and portions of the first and 
third strand are highly twisted, allowing residues from both to insert into the major 
groove, which would otherwise only be able to accommodate recognition residues from 
two of the three strands.  A recent solution structure of the λ-Int-N domain, however, 
shows the opposite; none of the residues projecting outward from the central strand make 
base-specific contacts with its DNA binding partner.  Instead, residues from the first and 
third strands are primarily responsible for base recognition, as well as a residue which 
originates from the β1β2 loop.  Strand β1 is highly twisted, and also contains a bulge, 
which appears to allow residues from both strands β1 and β3 to insert into the major 
groove (113). 
Unlike comparisons of RNA-binding dsRBDs, the significance of sequence 
alignments of DNA-binding dsRBDs is in the lack of conservation in key binding regions 
(see Figure 2.13.)  Sequence conservation of DNA-binding dsRBDs is extremely limited 
(the AtERF1 and Tn916-Int-DBD domains, for example, retain only 12% sequence 
homology when their secondary structural elements are aligned) especially among the 
externally-facing residues of the β-sheet.  This lack of conservation reflects the ability of 
DNA-binding dsRBDs to recognize and bind different DNA sequences through base-
specific major groove contacts.  Only one study has compared the sequences of DNA-
binding dsRBDs.  In 2000, Connolly et al. reported a comparative analysis of the Tn916-
Int-DBD/DNA complex with the previously published AtERF1 and I-PpoI structures  
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A. 
                                                        
          ---------------->>>>>>---->>>>>>>------>>>>>>----- 
Ppo1 ...QGTLHCYEIPLAAPYGVGFAKN-GPTRWQYKRTINQV---VHRWGSHTV... 
                         eiebe    e%eiebb       eiei          
Aterf ...AVTAAKGKHYR---G-VRQRPW-G-KFAAEIR-DPAKNGARVWLGTFET...  
                       beieie*eb  b%eieiebi      eiei bi    
Tn916 MSEKRRDNRGRILK-T-G-ESQRK-DG-RYLYKYIDSF--GEPQFV-YSWKL... 
                       beieieb    b%eieiei      eiei-e b     
λINT      MGRRRSHERRDLPPNLYIRNN-G-YY--CYRDPRT-G-K-EF-GLGRD...  
                  b     iibiebe   b%--eibii     b-ei-ei   
                   +  G/P   +   G  %   h h    G    h          
 
B. 
        -----------K-P^h^u--+--GDG-%-h-h-h-G--%-------u--- 
        -------------->>>>>>>>----->>>>>>----->>>>>>----- 
VHML   QEEDQKVSWPKAKDIKVQ--SKKEGD-MWHVWTEVNGMRWEN-WS-KGR-K... 
                      eie  ie e   e%eieie   ieiei ei         
KO2    AEVAEQEEKHPGK-PNFKA-PRDNGDGTYMVEFEFGGRHYAW-SGAAGN-R... 
                      eie  ie e   e%eieie   ?e  i ei          
N15    EEGPEEHQPTALK-PVFKP-AKNNGDGTYKIEFEYDGKHYAW-SGP-ADSP...  
PY54YC SDNASDEDKPEDK-PRFAAPIRRSED-SWLIKFEFAGKQYSW-EG-NAESV...  
VP882  VPAAEKQPKKAQK-PRLVAH-QV-DDEHWEAWALVEGEEVAR-VKIKG-TR... 
Halm   VAAAVPKEVAEAK-PRLNAHPQ--GDGRWVGVASINGVEVAR-VGNQAG-R... 
VCamp  VVETKPKDETVIK-PKMKGH-K-EDDGTWLVDVTIEDKSWQISVGKEPKNV... 
 
 
Figure 2.13  Comparison of β-strand residues of DNA-binding dsRBDs and 
protelomerase far CTDs.  
A)   Sequences of DNA-binding dsRBDs are aligned according to secondary sequence, 
with the orientation of residues (internally or externally facing) indicated beneath each 
sequence.  Within each sequence, externally-facing residues are indicated with colored 
text, and residues important for base-specific interaction (as described in the original 
manuscripts) are shown in bold text and are underlined.  Symbols representing 
orientation of residues are as follows: interior facing residue, (i); backbone-interacting 
residue, (b); other external facing residues, (e); conserved, interior-facing aromatic 
residue in strand β2, (%).  A consensus sequence is located below the alignment. 
B)  Sequences of Tel-VHML and Tel-KO2 are shown, with orientation of residues in β-
strands indicated beneath each sequence as in A.  The putative protelomerase farCTDs 
are also shown, and are aligned according by the relatively high conservation of 
hydrophobic residues found at roughly alternating positions within the strands.  Residues 
with relatively high conservation are indicated with red text and are underlined.  A 
consensus sequence is located above the alignment. 
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(112).  After noting the minimal sequence conservation Connolly instead noted four 
related, positionally conserved, DNA-protein contacts.  These included two interfacial 
contacts to the phosphodiester backbone (a glycine prior to strand β1 and a positively 
charged residue at the beginning of strand β2) and two base-specific hydrogen bonds 
(originating from the second external residue on strand β1, and from a charged residue in 
strand β2.)   
The λ-Int-N-domain structure published after Connolly‟s study reduces 
conservation even further.  The conserved anchoring residues noted in Connolly‟s study 
(the glycine located just proximal to strand β1 and the basic residue which is the first 
externally facing residue of strand β2) are replaced in the λ-Int-DBD structure by Pro14 
and Tyr23, respectively, and there are no specific base contacts originating from strand 
β2.  However, the addition of the λ-Int-N-domain to the fold highlighted conservation 
that was not as obvious in the comparison of the three prior structures.  Not present in the 
I-Ppo1 structure, but conserved among the three proteins which maintain the dsRBD fold 
is a basic residue located before strand β1 which appears to interact with the 
phosphodiester backbone in a manner to further anchor the domain within the major 
groove.  The structures also all contain a conserved basic or polar residue at the end of 
the strand β1 which is poised to interact with the phosphodiester backbone.   
In terms of overall architecture, there is much more variability in the DNA-
binding structures than in RNA binding dsRBDs.  The length of the individual strands 
which make up the β-sheet varies from protein to protein, and the presence and level of 
twist among strands varies significantly as well.  In AtERF1, a beta bulge in strand β3 
serves to accommodate a proper fit against the proximal DNA strand, while λ-Int-N-
82 
domain has a β-bulge in strand β1.  In Tn916, an extra insertion between strand β3 and 
the alpha helix creates a loop which specifically interacts with bases just 3‟ of the dsRBD 
binding site, while the λ-Int-N-domain has recently been shown to have an extended 
region N-terminal to the dsRBD which becomes structured on binding, making two 
additional contacts in each of the major and minor grooves.  The extended segment forms 
a short 3
10
 helix and then wraps around the DNA strand, inserting into the minor groove 
(113).)  Among the four DNA-binding dsRBDs, the length and orientation of the alpha 
helix to the β-sheet also display significant variability (see Figure 2.12.)  Despite these 
differences, the general size, conformation, and fit of all structures within the major 
groove are analogous, and clearly define a structural fold and binding motif.   
 
Protelomerase farCTD/dsRBD class comparison 
Both the observed similarities and variablilities of different aspects of the Tel-
KO2 and Tel-VHML structures are more consistent with DNA-binding dsRBDs than 
with RNA-binding dsRBDs.  The protelomerase farCTDs share the overall architecture of 
DNA-binders (βββα), with comparable lengths for individual β-strands and intrastrand 
loops (see Figure 2.12.).  The β1β2 loop in particular (important in RNA recognition for 
RNA-binders) is shorter in both DNA-binding dsRBDs and the protelomerase farCTD 
than in RNA-binding dsRBDs (Figure 2.8).  The length and orientation of the alpha helix 
to the β-sheet show much more variability in the βββα structures than those observed in 
RNA-binders.  The paradigm of two of the three β-strands of DNA-binding dsRBDs 
being more significant in DNA recognition is also reflected in the protelomerase 
farCTDs, with the β2β3 strands of the Tel-VHML being longer and more well-defined, 
while in the farCTD of Tel-KO2 strands β1β2 are better defined.  The sequence 
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alignment and secondary structure prediction calculations of the putative protelomerase 
farCTDs with those of the solved protelomerase farCTDs indicates that they also will 
also reflect the DNA-binding dsRBD characteristics, including identical architecture, 
similar strand length, and variability in helix length.  Like the DNA-binding dsRBDs, all 
solved and putative protelomerase farCTDs have a conserved basic residue prior to the 
start of strand β1, and an additional basic residue positioned to be homologous to the 
second externally-facing residue of strand β1.  All known and putative protelomerase 
farCTDs except that of Tel-VHML have a conserved proline antecedent to strand β1, 
reflective of the λ-Int-N-domain (see Figure 2.13).   
It is especially interesting that the λ-Int-N-domain belongs to the protein with 
which protelomerases share a catalytic mechanism and significant core domain 
homology.  Lambda integrase is often considered the archetypal member of the tyrosine 
recombinase family, and it is this family that is most closely related to protelomerases in 
general.  In fact, based on the similar overall genome organizations and close 
relationships of phages N15, KO2, and PY54 with E. coli phage λ and other lambdoid 
phages, it has been suggested that these protelomerase-containing phages should be 
classified as a lambdoid phage subgroup (44).  Lamdba integrase has even been noted to 
produce covalently closed ends at att sites in in vitro experiments where mismatches are 
present in the core region (114).  The λ-Int-N-domain is N-terminal to the two-lobed 
catalytic and core-binding domains which make up the λ-integrase central region and is 
attached by a flexible linker.  The close relationship of λ-integrase to protelomerases, and 
their similarity in architecture suggests that the dsRBDs of protelomerase and λ-integrase 
may serve a related function.  The λ-integrase N-domain recognizes and binds accessory 
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DNA (called ARM sites) outside of the core-binding site during integration and excision 
((61) for a recent review.)  Lambda integrase forms a four-part multimer, and the N-
domains (also called ARM-binding domains) appear to influence equilibrium of the 
recombination reaction by shaping the complex via their interaction with each other in 
addition to their interaction with accessory DNA (60).  The function of the λ integrase N-
domain not only suggests that the protelomerase farCTD binds DNA, but provides a 
precedent for a possible second, protein based interaction in its role.   
 
Sequence conservation between a DNA binding dsRBD and a  
putative phage protelomerases farCTD 
Conservation of key residues between a known DNA-binding dsRBD and a 
putative phage protelomerase farCTD along with accompanying cognate DNA sequence 
conservation further provide compelling indication that the farCTD binds DNA.  The 
Tn916-Int-DBD is the DNA-binding dsRBD for which the most structure/function 
information is known.  Tn916 is a well-characterized conjugative transposon encoding 
tetracycline resistance that excises and integrates in a manner similar to E. coli 
bacteriophage λ.  The protein that accomplishes both the strand cleavage and rejoining 
aspects of transposition is the transposon-encoded integrase (Int) which is composed of 
two domains (115).  The C-terminal, catalytic domain is, like the minimally 
enzymatically active N-terminal region of Tel-KO2, a member of the tyrosine family of 
site-specific integrases.  It recognizes and cleaves inverted repeats at the 
transposon/chromosome junction.  The catalytic domain is delivered to the site of 
recombination by the site-specific interaction of the N-terminal domain with its cognate 
DNA, which binds distally to the point of recombination (116) at inverted repeat sites 
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within the transposon arm (115, 117, 118).  The size of the N-terminal DNA binding 
domain (called Tn916 Int-DBD) has been experimentally determined, and a structure of 
the isolated domain bound to its cognate DNA has been reported (76). Like the λ-Int-
ARM binding domain, the Tn916-Int-DBD belongs to the dsRBD structural fold.   
In 2000, Connolly et al. reported a series of rational mutagenesis and binding 
affinity assays to determine the specific protein residues and DNA bases along the 
binding surfaces of the Tn916 Int-DBD and its cognate DNA that are responsible for 
affinity.  A series of fluoroscein-labeled and natural fluorescence assays monitored the 
effect of substitutions and point mutations on affinity (112).  The residues whose 
mutations resulted in the highest affinity decrease were also identified as being 
responsible for base-specific interaction with the cognate DNA through unambiguous 
hydrogen bonding according to the solved structure.  The residues responsible for these 
base-specific interactions were located on the external face of the β-sheet on all three 
strands.  Additional important phosphate/hydrogen bond and base/residue van der Waal 
interactions were also noted.  The base-specific hydrogen bonding interactions included 
R20 in strand β1, K28 in strand β2, and Y40 in strand β3.  Phosphate contacts included 
G16 (amide hydrogen) and K21 in β1 and W42 in strand β3.  Base van der Waals 
contacts, such as those originating from L26 in strand β2 and F38 in strand β3 were 
noted, but X to A mutation caused a much lower drop in DNA binding affinity.   
A putative protelomerase farCTD with otherwise minimal conservation to the 
Tn916-Int-DBD contains nearly all of the residues noted in the Tn916-DBD mutagenesis 
study to significantly decrease binding affinity to cognate DNA when mutated.  PY54 is a 
temperate phage which infects Yersinia enterocolitica, a gram-negative bacterium 
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belonging to the Enterobacteriaceae family.  During its lysogenic phase, PY54 is 
harbored within Y. enterocolitica as a linear plasmid prophage with covalently closed 
hairpin ends (52).  A 77kDa protein PY54 protein with sequence homology to the phage 
N15 protelomerase has been found to process recombinant plasmids containing a 42bp 
palindrome natively found upstream from the PY54 protelomerase-like gene on ORF 32 
of the PY54 phage genome.  The sequence of the 42bp palindrome reflects the sequence 
of the processed hairpin ends and also has some similarity to the protelomerase binding 
sites of Tel-N15 and Tel-KO2.  In vivo protelomere creation has been shown to require 
both the protelomerase-like gene and the 42kb palindrome, as well as 15 bp inverted 
repeat sequence which flanks the palindrome at differing distances (66bp left, 45bp 
right), for efficient processing (51).  Sequence alignment of the PY54 protelomerase (Tel-
PY54) with solved phage protelomerases shows a probable farCTD with secondary 
structure prediction that is similar to those predicted for the Tel-VHML and Tel-KO2 
farCTDs.  Based on the PY54 secondary structure prediction and on sequence alignment 
with both solved protelomerases and DNA-binding dsRBDs, residues with probable 
positional homology to the Tn916-Int-DBD residues were identified.  Table 2.3 shows 
the comparison of the Tn916 Int-DBD and the putative PY54 protelomerase farCTD 
along with the published values for affinity decrease caused by sequence mutation of the 
Tn916 Int-DBD.  Figure 2.14 shows the sequence alignment of the Tn916 Int-DBD β-
strands with the putative Tel-PY54 farCTD.   
The DNA oligomer used in the solution structure of the Tn916-Int-DBD/cognate 
DNA complex, was the consensus sequence of the five Tn916-Int-DBD binding sites (5‟-







Comparison of Tn916 Int-DBD residues important for DNA binding affinity to probable 
positionally homologous residues of putative PY54 protelomerase farCTD. 
 
Tn916 mutation Fold affinity 
decrease 
Residue location Contact type PY54 farCTD 
comparison 
Y40A 14 Strand β3 Base H-bond Y606 
K54A 10 Extended loop Phosphate H-bond None 
K28A 11 Strand β2 Base H-bond K598 
R24A 8 Strand β2 Phosphate H-bond S594 
K21A 3 β1β2 loop Phosphate H-bond R590 
R20A 2 Strand β1 Base H-bond R589 
W42A 2 Strand β3 Phosphate H-bond W608 
L26A 1 Strand β2 Base vdW contact L596 







Figure 2.14  Comparison of the external facing residues of the β-sheet of transposon 
Tn916 Integrase DNA-binding domain (Tn916-Int-DBD) to the probable homologous 
residues of putative protelomerase farCTD Tel-PY54. 
A)  The externally-facing residues of the Tn916-Int-DBD β-sheet are shown in the 
context of the three strands which make up the sheet.  The strand number is indicated 
above the sequences, and internally-facing residues are indicated by the small letter (i), 
while the externally facing residues are numbered as described in the manuscript 
reporting the solved structure, and the interior-facing anchoring aromatic residue located 
in strand β2 is indicated by a % symbol.  Externally facing residues shown in Connolly‟s 
study to result in a significant decrease in cognate DNA binding affinity when mutated 
are highlighted, and the residue number in context of the full-length protein is indicated 
below the sequences of the β-sheets.  The homologous residues for putative 
protelomerase farCTD Tel-PY54 were identified by secondary structure prediction and 
by sequence alignment with solved Tel-KO2 and Tel-VHML farCTDs.  Numbers of the 
probable positionally homologous residues are indicated below the sequence.  The fold 
affinity decrease caused by X to A mutation in Connolly‟s Tn916 study is indicated 
below both sequences.   
B)  Sequence alignment of the Tn916-Int-DBD with putative the farCTD of 
protelomerases PY54 along with the farCTDs of Tel-VHML and Tel-KO2 showing the 
reasoning for the identification of probable homologous residues between PY54 and 
Tn916-Int-DBD.  The secondary structure elements based on the solved structures 
(Tn916-Int-DBD, Tel-VHML, Tel-KO2) or the predicted secondary structure (putative 
Tel-PY54) are indicated by highlighting (β-sheet in yellow, α-helix in grey).  The 
residues in the TN916-Int-DBD noted in Connolly‟s mutation analysis to significantly 
reduce DNA binding affinity on mutation are indicated by bold, red type.  Residues noted 
for specific base interaction (either hydrogen bond or van der Waals) are underlined.   
C)  Sequence alignment of all known and putative protelomerases.  The secondary 
structure elements (either of solved structures or likely homologous structures) are 
highlighted as in (B.) and are indicated above the sequence alignment (β for β-strand, α 
for α-helix.  Conserved residues are indicated in red text. 
D)   Secondary structure prediction of the far C-terminal region of putative protelomerase 
Tel-PY54 as calculated by the PSIPRED program.  The prediction is similar to those of 
the solved farCTDs of Tel-KO2 and Tel-VHML, in which only two of the three β-strands 
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1Tn9   EKRRDNRGRILK-T--GESQRKDG--RYLYKYIDSFGEPQFVYSWKLVATDRVPAGKRDAISLREKIAEL  
Py54  SDNASDEDKPEDK-PRFAAPIRRSED-SWLIKFEF-AG---KQYSWEGNAESVIDAMKQAWTENME   
KO2   AEVAEQEEKHPGK--PNFKAPRDNGDGTYMVEFEF-GG---RHYAWSGAAGNRVEAMQSAWSAYFK*  
VHML      DQKVSWP-KAKDIKVQSKKEGD-MWHVWTEV-NG--MRWENWS-KGR-KTEAVKALRQQYERESAEM  
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C.  farCTD sequence comparison 
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KO2    AEVAEQEEKHPGK-PNFKA-PRDNGDGTYMVEFEFGGRHYAW-SGAAGN-RVEAMQSAWSAYFK        
N15    EEGPEEHQPTALK-PVFKP-AKNNGDGTYKIEFEYDGKHYAW-SGP-ADSPMAAMRSAWETYYS        
PY54YC SDNASDEDKPEDK-PRFAAPIRRSED-SWLIKFEFAGKQYSW-EG-NAESVIDAMKQAWTENME        
VP882  VPAAEKQPKKAQK-PRLVAH-QV-DDEHWEAWALVEGEEVAR-VKIKG-TRVEAMTAAWEASQKALDD    
Halm   VAAAVPKEVAEAK-PRLNAHPQ--GDGRWVGVASINGVEVAR-VGNQAG-RIEAMKAAYKAAGGR       
VCamp  VVETKPKDETVIK-PKMKGH-KE-
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D. PY54 secondary structure prediction 
 
 
A.   β1    β2  β3   
  1i2i3    %1i2i3i  1i2i3 
Tn916 KTGESQRK  RYLYKLID  PQFVYSW 
                16      20 21   24  26  28                  40  42 
PY54 RFAAPIRR  SWLIKFEF    KQYSW 
                    585      589 590    594  596  598                      606 608 
Affinity decrease        2 3     8  1   11                  14  2 
 
confidence of prediction 
Pred:  prediction of secondary structure 
AA:  amino acid sequence 
conf: =  helix 
=  strand 







other known DNA-binding dsRBDs in the presence of an extended loop between the 
third strand of the β-sheet and the terminal alpha helix.  The solved structure of the DBD 
DNA complex shows that the extended loop inserts in a region just outside that 
recognized by the dsRBD‟s β-sheet, which binds across the sequence 5‟-GTAGTA-3‟.  
Four bases within the cognate DNA oligomer are specifically recognized by externally 
facing-residues from the three-stranded β-sheet (see Figure 2.15).   Lys28 recognizes two 
base-steps through its side-chain amine group, donating a hydrogen bond to G3‟s O6 and 
N7 atoms and to T4‟s O4 atom.  Nucleotide substitutions resulting in the loss of either of 
these contacts (such as G3A or T4C) causes a tenfold reduction in Tn916-Int-DBD-DNA 
affinity levels.  Tyr40 also recognizes two base-steps through its side-chain, with the 
hydroxyl group accepting a hydrogen bond from C21‟s N4 amine group, and donating a 
hydrogen bond to A20‟s N7 atom.  Nucleotide substitutions that disrupt this interaction 
by eliminating either the N4 amine group of C21 (G6A/C21T) or potential contacts to the 
purine ring at base-step 7 (T7G/A20C) cause 26 and 16-fold reductions in respective 
affinity levels. 
Although the precise location of the binding partner of the putative PY54 
protelomerase farCTD cannot be definitively determined without further 
experimentation, the PY54 palindromic DNA recognition site provides an indication of 
one possibility.  The DNA sequence recognized by the dsRBD-like portion of the Tn916-
Int-DBD is also present in the palindromic PY54 protelomerase binding site.  Just 
downstream of the PY54 palindrome‟s central six base-pairs (the last of which is a 3‟-G) 
is the sequence 5‟-TAGTA-3‟, while just upstream of the central palindrome is an 










Figure 2.15  Effects of base-step substitution of Tn916 Int-DBD cognate DNA on 
complex affinity, and comparison to PY54 protelomerase target site. 
A)  The sequence of the oligomer used in both NMR structural studies and in the intrinsic 
fluorescence quenching studies of the Tn916 Int-DBD-DNA complex reported by 
Connolly et al. (112).  The highlighted portion indicates the region of the oligomer in 
which the dsRBD binds, excluding the interaction of the extended loop between strand β3 
and the alpha helix.  Bases which are specifically recognized by side-chains of externally 
facing residues of the β-sheet are underlined.   
B)  As reported by Connolly et al., individual base-step substitutions within the oligomer 
are shown and their corresponding effect on Tn916-Int-DBD binding affinity is indicated.  
The decrease in binding affinity is reported as fold decrease compared to the wild-type 
oligomer, and is listed above each base-step substitution shown.  The Tn916-Int-DBD 
residue that interacts with the wild-type base is shown above or below the substituted 
base, along with the percentage of conformers from the solved structure that were seen to 
interact with the wild-type base.  A description of the wild-type residue/base interaction 
is shown below each substituted oligomer. 
C)  Protelomerase PY54 target site.  The palindromic region (excepting the central six 
base-pairs) is underlined.  Regions with sequence similarity to the dsRBD-binding 
portion of the Tn916-Int-DBD cognate site are highlighted.    
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A.  Oligomer used in Tn916-Int-DBD studies 
      10 16    26 16       (fold affinity decrease on base-step substitution)     
G1 A2 G3 T4 A5 G6 T7 A8 A9 A10T11T12C13   
C26T25C24A23T22C21A20T19T18T17A16A15G14 
                   
 
 
B. Base-step substitutions and their effect on Tn916-Int-DBD affinity.   
 
 
G3A substitution (10 fold reduction)   C21T substitution   (26 fold reduction) 
   K28   
A2 A3 T4 A5 G6 T7 A8      A2 G3 T4 A5 A6 T7 A8  
T25T24A23T22C21A20T19    T25C24A23T22T21A20T19 
          Y40 (95%) 
K28‟s amine group donates an H bond   Y40‟s hydroxyl accepts an H bond from  




T4C substitution (16 fold reduction)    A20C substitution (16 fold reduction) 
     K28 (35%) 
A2 G3 C4 A5 G6 T7 A8    A2 G3 T4 A5 G6 G7 A8    
T25C24G23T22C21A20T19   T25C24A23T22C21C20T19 
              Y40 (55%) 
(K28‟s amine group donates an       Y40‟s hydroxyl donates an H bond to  
H bond to T4‟s O4 atom)        A20‟s N7 atom 
 
 





Figure 2.15).   
The homologous β-sheet residues for other known and putative protelomerase 
farCTDs do not match any of the other known DNA-binding dsRBDs, so their likely 
cognate DNA binding sequences cannot be as easily identified.  However, the pattern of a 
5-6 base sequence just downstream of the central six base-pairs of the palindromic 
protelomerase target site being imperfectly repeated at the far 5‟-end of the palindrome is 
also present in the other known protelomerase binding sites (see Figure 2.16).  This 
sequence pattern of the palindromic protelomerase binding site provides an intriguing 
possibility for future studies seeking to identify the binding partner of the protelomerase 
farCTD in an effort to elucidate the function of this interesting domain.      
 Py54 (51) 
  AATTAAAGTAACCCA-(65)-ATAGTCACCTATTTCAGCATACTACGC-GCGTAGTATGCTGAAATAGGTTACTGT-(39)-TGGGTTACTTTAATT 
  TTAATTTCATTGGGT-(65)-TATCAGTGGATAAAGTCGTATGATGCG-CGCATCATACGACTTTATCCAATGACA-(39)-ACCCAATGAAATTAA 
 
KO2  
             CATAACACGATAGGAGTACATAACAGCACAcAAcAGCCCATTATACGC-GCGTATAATGGGCTaTTaTGTGCTGATTATCGTAACACAGTCGCACATTG 
                TTGTGCTATCCTCATGTATTGTCGTGTgTTgTCGGGTAATATGCG-CGCATATTACCCGAtAAtACACGACTAATAGCATTGTGTCAGCGTGTAA 
 
N15 (54) 
        CaTATCAGCACACAATtGcCCATTATACGC-GCGTATAATGGaCtATTGTGTGCTGATAAG  
    GtATAGTCGTGTGTTAaCgGGTAATATGCG-CGCATATTACCtGaTAACACACGACTATtC 
 
VHML (119) 
     TATTTAATTGACATgtgtatGGTTGAACGGTGTCCACAT-ATGTGGACACCGTTCAACCATACACATGTCAATATGAT  
     ATAAATTAACTGTACACATACCAACTTGGCACAGGTGTA-TACACCTGTGGCAAGTTGGTATGTGTACAGTTATACTA 
 
VP58.5 (48) 
      TAACTGTACATATACCAACCTGCACAGGTGTACATATAGTCTAA-TTAGACTATATGTACACCTGTGCAGGTTGGTATATGTACAGTTA 
      ATTGACATGTATATGGTTGGACGTGTCCACATGTATATCAGATT-AATCTGATATACATGTGGACACGTCCAACCATATACATGTCAAT 
 
Halm ΦHAP-1 (43) 
   CCTATATTGGGCCACCTATGTATGCACAGTTCGCCCATACTATAC-GTATAGTATGGGCGAACTGTGCATACATAGGTGGCCCAATATAGG 
     GGATATAACCCGGTGGATACATACGTGTCAAGCGGGTATGATATG-CATATCATACCCGCTTGACACGTATGTATCCACCGGGTTATATCC 
 
VP882 (49) 
    ATATACATATAGCCCTAGGGCAAGGTATGTATGTACATAGGTACACCCATACTATAC-GTATAGTATGGGCTACAATGTACACCATAGTAAGCCCTAGGGCAAGGTATGTATAT 
    TATATGTATATCGGGATCCCGTTCCATACATACATGTATCCATGTGGGTATGATATG-CATATCATACCCGATGTTACATGTGGTATCATTCGGGATCCCGTTCCATACATATA 
 
 
Figure 2.16  Comparsion of the binding sites of known phage protelomerases. 
The pattern of a 5-6 base sequence just downstream of the central six base pairs of the palindrome and an imperfect match at the 5‟ 
end of the palindrome is repeated for all known and putative protelomerase target sites.  Blue text on the Tel-KO2 target site indicates 
the region of naked DNA.  Red text indicates the 5-6 pair sequences which may be the site of farCTD binding.  Lowercase font 














This dissertation has focused on understanding the structure and function of the 
far C-terminal region of phage protelomerases.  Our work has identified the structured 
portion of the far C-terminal region of two phage protelomerases and has shown that the 
regions form a well-defined, homologous domain.  The domain has been called the far C-
terminal domain (farCTD).  It is composed of a contiguous, three-stranded, anti-parallel 
β-sheet which wraps around and binds against a C-terminal alpha helix.  Sequence 
alignment and secondary structure predictions show that all known and putative phage 
protelomerases contain C-terminal regions which will almost certainly form homologous 
domains.  The farCTD belongs to the structural superfamily known as the double-
stranded RNA-binding domain (dsRBD), although the protelomerase farCTD differs 
from the canonical dsRBD in lacking an additional N-terminal helix.  This modified 
architecture (βββα) is identical to that of a small subgroup of the dsRBD superfamily 
which is known to bind DNA in a sequence specific manner through the insertion of the 








The structure of the farCTD paves the way for a more comprehensive 
understanding of its role in the functioning of the protelomerase enzyme.  The 
mechanism of hairipin telomere formation is beginning to be understood, and a crystal 
structure of the Klebsiella oxytoca phage ΦKO2 protelomerase core domain lacking the 
farCTD has been reported, but a number of questions remain, and it is likely that an 
understanding of the farCTD will be closely interconnected in answering these questions 
(29, 64).  
 
What is the binding partner of the farCTD? 
In determining the function of the farCTD, it seems unlikely that the farCTD 
would be able to perform any kind of enzymatic function, especially as an isolated 
domain.  Given the catalytic studies and the precedence of the function of other dsRBDs, 
it is far more likely that the role of the farCTD is to bind to and interact with other 
macromolecules.  Although initial binding studies were inconclusive, sequence and 
structure comparisons of the farCTD and full-length protelomerase with other dsRBD-
containing proteins indicate that the protelomerase farCTD likely interacts with DNA.   
Compared with consensuses of DNA and RNA binding dsRBDs, the 
protelomerase farCTD is most like DNA-binders in terms of overall architecture, loop 
and strand length, and presence and absence of sequence conservation in key regions.  
Specifically, the farCTDs mimic the βββα topology, shorter loops, and more variable 
strand length, helix length, and helix angle of the DNA binding dsRBDs.  Sequence 
comparisons of the solved and putative farCTDs with a consensus of DNA and RNA 
binders also show that the farCTD is more closely related to DNA binding dsRBDs.  
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Significant conservation exists in the three RNA interacting regions of RNA-binding 
dsRBDs, and none of the conserved residues within these motifs are conserved in the 
farCTDs.  For DNA-binding dsRBDs, there is a significant lack of conservation among 
important DNA-recognition regions (the external face of the β-sheet) reflecting the ability 
of DNA-binders to base-specifically recognize short DNA sequences.  Instead, there is 
conservation in regions poised to interact with the DNA backbone, including positively 
charged and polar residues prior to and at the end of strand β1.  When aligned by the 
hydrophobic residues conserved among all three dsRBD classes, solved and putative 
farCTDs follow the paradigm described by DNA-binding dsRBDs.  There is a lack of 
conservation among the residues of the β-strand likely to be externally facing, while the 
positive residues which in the DNA-binders are poised to interact with the DNA 
backbone are universally conserved among the putative farCTDs. While it is difficult to 
predict with absolute certainty which residues of the strands of putative farCTDs will be 
externally facing due to the possibilities of β-bulges and other strand anomalies, there 
seems to be very limited conservation for farCTDs in these regions.     
The homology of full-length protelomerase to its closest relatives also suggests 
that the farCTD binds DNA.  Protelomerases share sequence homology and a catalytic 
mechanism with type IB topoisomerases and the site-specific recombinase family known 
as tyrosine recombinases (22, 27, 28).  The archetypal member of the tyrosine 
recombinase family is λ-integrase from the temperate coliphage λ.  Like the solved 
protelomerase Tel-KO2, λ-integrase has a multi-lobed central region and a small domain 
attached by a flexible liker.  In λ-integrase, this N-terminal domain, a member of the 
DNA-binding family of dsRBDs, sequence specifically binds DNA at sites distal to the 
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site of recombination and shapes the recombination complex via interaction with other N-
domains in the reactive multimer (60).  The close relationship of λ-integrase to 
protelomerase in terms of sequence conservation, mechanism, and domain architecture 
suggests that the dsRBDs of protelomerase and λ-integrase may serve a related function.  
The precedent of the function of the λ-integrase N domain not only suggests that the 
protelomerase farCTD binds DNA, but provides a precedent for a second, protein based 
interaction in its role.  Several experiments suggest themselves in determining whether 
this theory is correct for the farCTDs.  Initial farCTD/DNA binding site studies were 
inconclusive.  However, it may be that the removal of the N-terminal region of the 
farCTD reduced DNA binding, as observed in the N-domain of phage λ-integrase, in 
which removal of only two of the unstructured N-terminal residues virtually abolished 
arm-type binding and recombinase activity (120).  A recent solution structure of the λ 
integrase ARM-binding domain has shown that the previously described “unstructured” 
N-terminal tail in fact wraps around the DNA strand and inserts in the minor groove, 
providing additional stabilizing DNA contacts (113).  Since our DNA affinity experiment 
used the shortened protein construct Tel-KO2 (593-640), the unstructured region was 
entirely absent.   
A number of possibilities exist in testing this hypothesis.  An obvious starting 
place is to repeat the previously attempted experiments which were inconclusive.  At 
least one BIACORE experiment using a much shortened DNA protelomerase target site 
was performed by the Huang lab using the TelKO2 protelomerase, but due to proprietary 
interests, the experiment set up and results could not be described.  Since that time, 
structures of both the core domain and the farCTD have been reported, and the increased 
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understanding of the Tel-KO2 will aid in experiment design and success.  Once the likely 
binding site has been confirmed, chemical shift mapping experiments can be repeated 
with optimized experimental conditions and procedures.  Initial attempts could follow the 
successful procedure used to map chemical shifts of λ-integrase N-domain (1-64) with 
and without a 14-basepair oligomer containing the P‟1 recognition site ((120, 121) for 
descriptions and protocols.)   
While the kinetic effect of protelomerase and target site truncation data in the 
KO2 system implies that the farCTD binds within the DNA palindrome, it may also serve 
another role in the phage life cycle.  The known protelomerase-containing phages are 
temperate phages, and replicate stably within their DNA hosts as linear plasmid 
prophages during their lysogenic phases.  However, the phages also have a lytic phase, 
and exist as circularly permuted phage DNA with overhanging, cohesive ends.  The 
conversion of the genome from phage to prophage form upon infection has been 
described.  The phage genome circularizes via the cohesive ends and is then cleaved by 
protelomerase to form a linear, hairpin-capped molecule.  The conversion from linear 
prophage to circularly-permuted DNA suitable for loading into phage heads within the 
lytic cycle is less well understood.  A recent study of the course of lytic development 
within the E. coli/N15 system showed that protelomerase is required for both plasmid 
replication and lytic development (122).  The authors present data consistent with a 
model in which the differential processing of the head-to-head circular genomic dimer 
known to be the intermediate of normal prophage replication would result in monomeric 
circular molecules.  The authors suggest that if protelomerase molecules processed a 
replicated dimer through a synaptic complex in which the protelomere dimer junctions 
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were held in close proximity and allowed to act in concert, the reaction mechanism could 
result in unit-length genome monomers by the switching of religation partners of the 
complementary protelomere junctions.  This model is reminiscent of the 
integration/excision of the phage lambda genome through the function of the lambda 
integrase enzyme.  Protelomerases could follow the lambda integrase prototype of 
bivalent binding in which the dsRBD (farCTD in protelomerases) binds outside of the 
core recognition site to aid in strand exchange, potentially in the flanking inverted repeat 
sites which have been identified for most protelomerase-containing phages (22, 48, 54).   
 
How does the farCTD enhance the creation of hairpin telomeres? 
Although the core portion of protelomerase Tel-KO2 (consisting of the N-
terminal, catalytic, and C-terminal domains) is sufficient to produce hairpin telomeres, 
prior studies have shown that the presence of the farCTD has a substantial effect on the 
efficiency of the protelomerase.  When acting on full-length DNA binding site, Tel-KO2 
constructs lacking the farCTD are only able to reach partial completion of hairpin 
resolution compared to full-length protelomerase, even at a 15X longer reaction time.  
Despite this observation, the precise role of the farCTD in hairpin production is 
unknown.  The domain may function to increase DNA binding affinity or specificity.  
Alternatively, it could bind to DNA in such a way that modifies the shape of the DNA, 
perhaps facilitating unwinding of coiled DNA, allowing more room for rearrangement of 
the hairpin-forming central region, or possibly promoting dissociation of the core 




How does the protelomerase dimer dissociate? 
The mechanism and timing of protelomerase dimer dissociation is unknown, 
especially with regard to hairpin formation.  The reported Tel-KO2 structures contained 
variations of suicide substrates so that hairpin formation was prohibited and the enzyme 
was trapped in an intermediate state.  These structures included a nicked palindromic 
DNA substrate with an orthovanadate (VO4
3-
) to mimic the scissile phosphate of a 
pentavalent transition state of DNA cleavage, and a covalent TelKO2-DNA complex, 
representing the phosphotyrosine intermediate following DNA cleavage.  As a result, less 
is known about the interaction of the protelomerase enzyme with the final hairpin DNA 
product.  A modeling experiment was conducted to roughly determine whether the Tel-
KO2 dimer observed in the crystal structures could accommodate juxtaposed hairpin 
ends.  Several previously solved tetrapeptide DNA hairpins were modeled into the 
approximate location of the original DNA substrate within the Tel-KO2 dimer to see if 
the structure could accommodate covalently formed hairpin ends.  Of the several solved 
tetrapeptide DNA hairpins used, only one (pdb accession code 1qe7) fit the observed 
TelKO2 crystal structure conformation without steric clash ((64, 123), supplemental 
information.)  The authors suggest hairpin formation could occur spontaneously 
following DNA cleavage through favorable entropic shift, and that the resulting steric 
effects could trigger hairpin dissociation.  It is also possible that steric restrictions 
disfavor hairpin formation until after Tel-KO2 dimer dissociation.  An intriguing 
possibility for the role of the farCTD exists in the possible DNA binding site 3‟ of the 
central six base pairs of the protelomerase core target sequence.  Binding in this location, 
the farCTD could serve to disrupt the binding of the catalytic region of the protelomerase 
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to the target DNA either to create room allowing hairpin formation to occur, or to disrupt 
dimer association after hairpins have formed.   
 
What is the fate of protelomerase once hairpin product has  
formed? 
A recent single-molecule study suggests that λ integrase forms a stable product 
complex that doesn‟t readily disassemble (124).  Likewise, it has been suggested that 
protelomerases may also remain bound to the resolved chromosome termini, which could 
help to protect chromosome ends (64).  Resolution of duplicated telomere sequences by 
full-length Tel-KO2 has been shown to be remarkably efficient (64).  However, Tel-KO2 
has a low reported enzyme turnover activity.  In fact, published studies of purified Tel-
KO2 acting on binding site-containing substrate in in vitro assays indicate such slow 
turnover so as to indicate stoichiometric activity.  The authors of the study suggested that 
the enzyme may become inactive at the end of each round of activity, or else require 
other cellular factors in order to act catalytically (29)  The low turnover does not appear 
to be the result of tight end-product binding, however, as purified DNA hairpin does not 
act as a competitor for the hairpin creation reaction nor, the authors reported, did it 
appear to be caused by the enzyme becoming unstable during reaction conditions 
(reported, data not shown.)  It is interesting to note that in unpublished studies by the 
Huang lab, TelKO2 protelomerase lacking the farCTD was sufficient to produce hairpin, 
but the formation was not only much slower, but seemed unable to process all substrate.  
Under similar conditions, hairpin formation for the native enzyme is complete in two 
minutes while the shortened enzyme results in only 50% conversion after 30 minutes.  
Absence of the farCTD significantly inhibited reaction progress and completion, and may 
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suggest that the farCTD aids in enzyme turnover.  Understanding the function of the 
farCTD will likely help answer the question of protelomerase turnover.  
Like Tel-KO2, the Borrelia burgdorferi protelomerase (often called ResT) does 
not appear to turn over during in vitro analysis.  In trying to determine whether the slow 
turnover was due to slow product release or product inhibition of reaction, it was 
discovered that ResT can fuse hairpin products to form double-stranded DNA (125).  
Interestingly, the authors state that the properties of hairpin fusion suggest that the 
reaction reversal does not occur after an initial hairpin creation reaction while the enzyme 
lingers in a post-resolution synaptic complex, but rather that fusion occurs independently, 
or after product release from a forward reaction (126).  The details of this reverse reaction 
in context of the low turnover of the enzyme will be informative to the functioning of 
farCTD-containing protelomerases.  Unlike the B. burgdorferi protelomerase (ResT), 
Tel-KO2 telomere end fusion activity has not been observed, and is not detectable in 
vitro even under high hairpin product concentration (64, 127).  Secondary structure 
prediction indicates that B. burgdorferi does not likely have an extended linker/farCTD.  
It may be that the farCTD interacts with hairpin product in a manner to inhibit or prevent 
this reverse reaction.   
 
How do the distal DNA target site ends contribute to enzyme  
efficiency? 
The crystal structures of the Tel-KO2 involved both a shortened protein construct 
(Tel-KO2 4-535, lacking the flexible region and the farCTD) and a shortened DNA 
oligomer (the central 44 basepairs, lacking the six most distal base pairs on either side.)  
The protein extends only to the distal ends of the shortened DNA, with the C-most 
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regions folding back toward the center of the oligomer.  The structure implies that the 
core domain does not contact the most distal basepairs, and does not explain how the 
distal DNA ends contribute to protelomerase activity.  Unpublished data by the Huang 
group has shown that shortening an oligomer containing the Tel-KO2 protelomerase 
DNA target site by only three base pairs on either side of the recognition sequence 
(resulting in a 50 vs. 56 basepair recognition site) reduces the activity of full-length 
protelomerase (as measured by creation of hairpin protelomeres) to 25% compared with 
activity on full-length DNA target.  Further shortening the DNA target has an even more 
drastic effect on enzyme activity.  A 42 basepair oligomer (only one basepair longer on 
either side than the oligomer in the crystal structure) reduces enzyme activity to less than 
1% compared to activity on full-length DNA target.  Interestingly, a shortened protein 
(Tel-KO2 1-531) partially restores enzyme activity on shortened 42 base-pair target sites, 
returning activity to 15% of that of wildtype enzyme acting on full-length target.  
Combined, these two unpublished experiments suggest that the farCTD may interact with 
the distal DNA ends.  
Integrase lambda shows a similar pattern of influencing enzyme activity.  Weak 
core-site binding of lambda integrase relies on the high-affinity arm-DNA binding of the 
N-domain for proper delivery of the core (catalytic) domain to its recognition sequence.  
However, the absence of accessory (arm) DNA inhibits core site binding compared to 
truncated lambda integrase mutants lacking the N-domain.  Addition of accessory (arm) 






What correlation do phage protelomerase farCTDs have to  
bacterial protelomerases? 
The two bacterial protelomerases are shorter than the phage protelomerases.  Most 
automated alignments do not show an obvious homology of the C-terminal region of 
either bacterial protelomerase to the farCTD of phage protelomerases.  However, the 
existing homology between phage protelomerase farCTDs is also sufficiently limited that 
automated alignment programs were unable to properly correlate them.  While no 
experimental data exists, the alignment data for Borrelia protelomerases with phage 
protelomerase farCTDs is compelling.  At this time, no structural data has been obtained 
for any protelomerase within the Borrelia family (usually called resolvase, or resT.)  
Whether or not the farCTD correlates specifically with the Borrelia protelomerases C-
terminal domain, a greater comprehension of protelomerase function in general could 
provide insight into possible future treatments for a number of significant human 
pathogens, most notably Lyme disease, a currently chronic and debilitating condition 
which is one of the fastest growing infectious diseases in both the United States and 
Europe. 
 
What scientific interest do phage protelomerases hold? 
Recently, a genetic engineering technique was described in which addition of an 
Tel-N15 recognition site and a to a normally circular plasmid results in a stably 
replicating linear construct within a Tel-N15 expressing host strain.  The resulting linear 
plasmid‟s hairpin ends are rendered safe from RecBCD nucleases both in vitro and in 
vivo (18).  The authors suggest that this new technique will be especially useful in a 
number of applications, including creating large linear constructs, assembling and 
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studying artificial chromosomes, and as a means to clone and study large linear viral 
genomes.  
Aside from technological application, the phage protelomerases hold significant 
scientific interest of their own.  Tel-VHML, for example, comes from the phage Vibrio 
harveyi myovirus like, which infects Vibrio harveyi, a free-living, gram-negative, 
bioluminescent marine bacterium of the Vibrionaceae family of proteobacteria.  V. 
harveyi is related to Vibrio fischeri, a symbiotic bioluminescent bacterium that colonizes 
the light organs of various marine organisms such as squid (129, 130). Vibrio classes also 
include cholerae, a human pathogen which causes cholera (131).  V. harveyi was 
originally described in 1936 and is named after Edmund Newton Harvey, a pioneer in the 
study of bioluminescence (132).  The species is ubiquitous throughout marine 
environments.  It contains at least ten different chitinases, and may be important in 
nutrient cycling in aquatic environments (131, 133).  V. harveyi is thought to be 
responsible for the milky seas effect, the widely observed but not fully understood 
phenomenon described by Jules Verne in his classic 1870 novel Twenty Thousand 
Leagues under the Sea (134). In this phenomenon, stretches of surface ocean water large 
enough to be observed from space become luminescent for up to days at a time (135).  
The currently favored hypothesis explaining the milky seas effect is that Vibrio harveyi 
associate with marine algae during algal blooms, allowing colony density great enough to 
allow the quorum sensing which regulates bioluminescence (136, 137).   
Almost all strains of Vibrio harveyi are non-pathogenic, but some have been 
reported to cause devastating outbreaks of disease among populations of marine 
invertebrates and vertebrates, causing a variety of disease states including infectious 
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necrotizing enteritis, eye lesions, skin ulcers, and vasculitis ((47), and the references 
therein).  Disease outbreaks have been particularly devastating among invertebrate 
marine aquacultures, with dramatic financial loss due to the high mortality rate (nearly 
100% with some strains) of infected animals, and the persistence and survival of virulent 
strains, which has been attributed to the resistance to antibiotics and disinfectants of the 
V. harveyi biofilms (46).  The disease, called vibriosis or bacterial luminosis, has been 
reported in prawn hatcheries, rock and spiny lobster aquacultures, sea cucumber 
aquacultures, and in pearl oysters ((47, 138, 139), and the references therein) and has 
most recently been associated with the rapid tissue necrosis of stony corals (140).  Vibrio 
harveyi pathogenicity has been recognized as a substantial threat, and a significant 
ongoing research effort is currently underway to attempt to ameliorate vibrio 
pathogenesis (139, 141-151) 
Infection with phage VHML has been heavily implicated in V. Harveyi virulence.  
VHML conferred virulence on previously naïve, avirulent strains with accompanying 
alteration of colonial morphology, haemolysis upregulation, and production of previously 
absent extracellular proteins antigenically similar to toxin components produced by 
virulent strains (45).  Later, infection of Vibrio harveyi by VHML was shown to cause 
changes to its phenotypic profile (152). 
The conferral of virulence by a phage of a previously naïve bacterial species is not 
unknown.  Cholera in humans is caused by the lysogenic conversion of nontoxigenic 
Vibrio cholera or Vibrio mimicus strains by a phage (CTXΦ) (153, 154).  Although V. 
harveyi is not usually characterized as a human pathogen, the medical journal Pediatric 
Blood & Cancer recently reported a pediatric oncology patient with central line sepsis 
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caused by a Vibrio harveyi infection, most likely contracted from swimming in the 
Mediterranean sea while on vacation (155).  Other current research examines the 
possibility that some Vibrio harveyi strains may indeed be pathogenic to humans on 
exposure to bathing water, as well as by consumption of infected seafood (156).  
Likewise, VP58.5, a 42-kb plasmid myovirus prophage has been associated with 
the serovar O3:K6 pandemic clonal complex (157).  This complex is responsible for a 
world-wide pandemic of seafood borne illness (158-162).  Interestingly, although the 
VP58.5 and VHML phages have very similar genetic profiles (gene sequence is 92% 
similar) they infect a different range of hosts (48).  
 
Conclusion 
As we come to understand the role of the farCTD in relation to the rest of the 
protelomerase, we will better understand how the enzyme itself functions.  A more clear 
understanding of the protelomere-formation mechanism will likely have far-reaching 
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Figure A.1.  Secondary structure prediction and comparative 
13Cα chemical shift indices 
support the solved structures of the farCTDs of Tel-KO2 and Tel-VHML. 
A) and C)  Graphical representation of secondary structure propensity based on the raw 
Cα chemical shift differences (Δppm) for Tel-KO2 (531-640) and Tel-VHML (450-509), 
respectively.  Dotted lines are positioned at 0.7 and -0.7.  Values > 0.7 indicate a 
propensity for helical conformation; values at -0.7 ≤ 0 ≤ 0.7 indicate a propensity for 
random coil; values < -0.7 indicate a propensity for β-strand or extended conformation.  
In both cases, a cartoon indicates the secondary structure as determined by NOE structure 
calculations:  arrows indicate extended or β-strand regions, while cylinders indicate α-
helices. 
B) and D)  Graphical representation of secondary structure prediction based on of the 
farCTDs of the Tel-KO2 and Tel-VHML protelomerases.  As indicated, cylinders above 
the displayed sequence indicate that the sequence is predicted to form an alpha helix, 
while arrows indicate a prediction for extended or β-strand conformation.  A line 
indicates a prediction for random coil.  The height of the bar above the graphical 
prediction indicator displays the relative confidence of the predictions.  Predictions made 
using PSIPRED program (82, 83).  Although the program predicts two β-strands for each 
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SPECIFICITY OF RNA-BINDING DSRBDS  
 
Introduction 
As the name suggests, the protein fold known as the double-stranded RNA 
binding domain (dsRBD) was first recognized by its ability to recognize and bind double-
strand RNA (dsRNA) (93).  Proteins containing RNA-binding dsRBDs have been found 
in proteins throughout eukaryotic, bacterial, and viral systems, and in one known 
example of archaea.  RNA-binding dsRBDs are involved in many different aspects of 
RNA function including RNA localization, posttranscriptional gene silencing, RNA 
editing, and translational repression.  Despite the varying roles these proteins, the 
domains have in common the ability to specifically recognize and bind dsRNA over 
single stranded RNA, DNA, or RNA/DNA hybrids.   
 
The binding specificity debate 
Beyond a preference for dsRNA, the question of binding specificity by the 
dsRBD is one of current debate and ongoing research.  Although most data suggests that 
dsRBDs do not impart binding specificity, increasing numbers of studies imply degrees 
of binding preference in some systems.  While most dsRBDs bind most dsRNA, it 
appears some dsRBDs bind dsRNA more tightly, with varying exclusivity.  Thus, the 
answer to the binding specificity debate will likely be multi-tiered, and the question must 
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be addressed diverging but related aspects: RNA sequence specificity, RNA helix 
geometry specificity, and RNA “secondary structure” specificity.   
 
Sequence specificity 
It is generally believed that individual dsRBDs do not bind with sequence 
specificity.  Solved dsRBD/dsRNA complexes show that the majority of minor 
groove/base contacts are water-mediated, and those that are not are to hydrogen bond-
acceptors present in all four bases, leaving the authors of a comprehensive 2004 review to 
conclude that there is no strong evidence to indicate that interactions by any known 
dsRBM are sequence specific (94).  The ability to recognize a broad range of dsRNA 
targets without a strict target sequence requirement would be beneficial in the roles 
played by some dsRBD-containing proteins. In proteins such as protein kinase R (PKR), 
which plays a major role in the cellular response to viral infection on activation by 
binding to dsRNA, or Dicer, an RNase III family member that cleaves dsRNA and pre-
microRNA (miRNA) into short dsRNA fragments called small interfering RNA (siRNA), 
an ability to recognize dsRNA targets without a strict sequence requirement would allow 
a greater range in target selection and resultingly, scope of enzymatic activity.   Even 
among proteins which ubiquitously recognize dsRNA, though, there are examples of 
sequence preference.  Although these preferences may frequently be a result of anti-
determinants, at least one example exists of a sequence determinant for dsRBD binding.   
A recent study seeking to map the determinants and anti-determinants of 
Escherichia coli RNase III binding to a minimal substrate found that an AU base pair 
within a specific region of substrate RNA hairpin acts as a determinant for enzyme 
activity.  In this example, the carboxamide group within a conserved glutamine in the 
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first α-helix of the dsRBD recognizes a uracil O2 atom in the canonical AU pair and a 
neighboring ribose 2‟-hydroxyl group.  Substitution with a CG or CI pair reduced binding 
(163).  It is especially interesting that this example of substrate differentiation was 
discovered in a system which had generally been considered to lack target discrimination 
entirely (164). 
Although no other examples of direct sequence requirement are currently known, 
many dsRBD-containing proteins have target preferences.  For example, using site-
specific affinity cleavage, Spanggord and Beal showed that dsRBD1 of PKR bound with 
a specific orientation on both a synthetic stem-loop RNA and VAI RNA, an adenoviral 
inhibitor of PKR (165).  Further tests on the synthetic stem-loop showed that binding was 
unaffected by disruptions in the helix caused by nucleotide mismatch and bulging.  Other 
examples exist of multiple dsRBDs within a protein binding with specific orientation, or 
different binding modes on a dsRNA target (92, 166). In this and other examples, it is 
likely that this preference for substrates comes in part from the differing helix geometry 
imparted by sequence.   
 
Helix geometry specificity 
Ideal A-form geometry of dsRNA is rare.  Bends, twists, and kinks within a 
dsRNA are inherent to a given sequence, as is the degree of flexibility of the helix itself.  
Because these “flaws” within a helix result in altered groove geometry, dsRNAs of 
different sequence may be more or less easily accessible to a given dsRBD, or allow a 
greater or lesser degree of induced fit on binding, all of which could contribute to 
dsRBD/dsRNA affinity.  Additionally, although the sequence of the dsRBD is relatively 
highly conserved, sequence differences do exist among recognized dsRBDs and these 
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differences in sequence ultimately result in a greater or lesser capacity for binding 
dsRNAs.   
 
Secondary structure specificity 
Although observed examples of sequence specificity by dsRBDs to dsRNA 
molecules are limited, preference to various RNA structural features has been observed.  
A 2006 study by Stefl and Beal allowed the development of an NMR-based model of the 
complex of the two dsRBMs of rat ADAR2 with the R/G loop, a well-conserved 70 
nucletotide stem-loop from the R/G site of the GluR-B pre-mRNA, which is often used as 
a model system for A-to-I editing.  In this study, chemical shift perturbation allowed the 
identification of the protein and RNA surfaces involved in complex formation, and 
showed that the individual dsRBMs bound separate and specific portions of the target 
RNA.  Purified, separate dsRBM1 recognized a conserved pentaloop, while dsRBM2 
recognized two bulged bases adjacent to the editing site, demonstrating structure-
dependent recognition by the ADAR2 dsRBMs.  Rnt1p endoribonuclease, the 
Saccharomyces cerevisiae homolog of bacterial RNAse III, specifically recognizes and 
cleaves RNAs with short (12-14 base pairs), irregular stem-loops capped by AGNN 
tetraloops that are interrupted by internal loops and bulges.   Two independent structural 
and biochemical studies of the Rnt1p dsRBD have showed that helix α2 binds to the 
tetraloop minor groove of either the 5‟ terminal hairpin of the snR47 precursor, one of its 
small nucleolar RNA substrates (167), or to various short stem-loop RNAs that mimic 
physiological targets (168).  Surprisingly, although direct base interaction of the tetraloop 
minor groove is apparent in the solved structures, it is not to the conserved A or G.  
Instead, the authors believe that specificity to the tetraloop minor groove came from the 
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“tuning” of the angle of helix α2 by a third, carboxy-terminal helix to the specific 
tetraloop shape.  Removal of this helix not only destabilized the protein, but removed its 
ability to specifically bind to short RNA hairpin substrates, although it retained the ability 
to bind to long dsRNA (167, 168).  Besides the third helix, other slight structural 
differences were observed:  helix α1 was shorter than other solved dsRBDs, and loop 1 
(between helix α1 and strand β1, observed to interact with the minor groove in all solved 
structures) was free to penetrate more deeply.  The results of both studies imply not only 
that subtle differences in sequence and structure can alter dsRBD binding capacity, but 
that interaction with other protein elements, in this case an additional carboxy-terminal 
helix, may help to convey specificity for an entire dsRBD-containing protein which a 
dsRBD alone cannot convey.   
 
Beyond a single domain:  Multiple copies of dsRBDs/other  
domains  
As suggested by the Saccharomyces cerevisiae Rnt1p recognition of AGNN 
tetraloops, preference of binding of an isolated dsRBD versus that of an entire dsRBD-
containing protein is sometimes different, and comes from elements or interactions 
outside of a single, standard dsRBD.  It has been theorized, for example, that multiple 
dsRBDs within a protein may increase specificity of dsRNA targets (97).  Within PKR, 
for instance, dsRBD2 and dsRBD5 may act in concert to determine the minimum PKR 
substrate target length (96).  In some cases, the presence of other domains within a 
dsRBD-containing protein may help to increase dsRNA binding specificity.  The recent 
structure of the catalytic Aquifex aolicus RNase III complex shows that the protein‟s 
catalytic domain also interacts with dsRNA, and the authors propose that there are four 
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main points of interaction, two from the dsRBD (loop 2 and helix α1--the minor groove-
binders as described for all classical dsRBD interactions) and two from the catalytic 
domain.  The authors theorize that the dsRBD selects and binds dsRNA, which allows the 
catalytic endonuclease domain to recognize sequence specificity and enact scissile bond 
cleavage (111).   
While it is likely that the specificity debate will rage for some time to come, even 
now binding determinants and anti-determinants are already known for some dsRBDs, 
and certainly more will be identified in the future.  Certainly, the secondary structure 
formation and inherent helix deformation caused by RNA sequences affect the ability of 
dsRBDs to bind, and the differences in individual dsRBDs also result in differential 
binding ability.  The identification of the specifics of these binding determinants, 















SUMMARY OF PROJECT ONE:  HIV  

















During my graduate career I had the opportunity to work on two separate projects 
related to the topic of protein structure determination using high-field NMR 
spectroscopy.  Both projects centered on understanding the structure of a nucleic acid-
binding protein in the larger context of determining how the protein structure affects its 
interaction with its nucleic acid binding partner.  The project for which the bulk of my 
dissertation work was directed was a collaboration with Professor Wai Mun Huang in the 
Department of Pathology at the University of Utah.  This project was a structural study of 
a novel domain of two homologous proteins.  The results of this project are described in 
chapters one through three of this document.  My second project was a collaboration with 
Matija Peterlin, a Professor of Medicine, Microbiology and Immunology at the 
University of California, San Francisco.  We sought to further understand the 
transactivation that occurs during replication of the HIV genome.  Transactivation 
overcomes the stalling of the transcriptional machinery which occurs after the initiation 
complex has formed and has begun full genome replication for the production of new, 
infective virions.  The process of transactivation involves the interaction of three 
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elements:  an HIV protein called Tat, which has been previously transcribed and 
translated, a hijacked human regulatory protein called cyclinT1 along with its kinase 
partner (CDK9), and a highly structured portion of the nascent, partially transcribed HIV 
genome, an RNA element called TAR.  Understanding the structural interaction of this 
trimeric complex would provide a deeper understanding of HIV transactivation.  The 
Peterlin lab had previously published results on successful transactivation in in vitro 
studies using a chimera of shortened CyclinT1 and Tat rather than whole, individual 
proteins.  My work in this project involved an attempt to identify an optimal chimeric 
construct for structure investigation, and initial studies in identifying a purification 
procedure for the selected chimera.  Information not available to us at the start of the 
project and results of related studies that have since been published have shown that the 
minimal chimeras we studied were inadequate to describe the transactivation system and 
inappropriate for structural study.  This appendix contains a description of my second 
project, including a discussion of the HIV transactivation, issues related to the project 
design, and an analysis of possible future directions for the project.   
 
Background 
HIV/AIDS: classification, prevalence and therapeutics 
Human immunodeficiency virus (HIV), a member if the retroviridae family, is 
responsible for the illness known as Acquired immune deficiency syndrome (AIDS).  
Since the identification of HIV as the etiological agent of AIDS nearly 25 years ago, 
approximately 60 million people have become infected with HIV/AIDS, and nearly half 
of those have died (169).  Currently, an estimated 33 million people are thought to be 
infected with HIV/AIDS (subtypes 1 and 2) according to the World Health Organization 
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(WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).  A world-
wide pandemic and the leading cause of death in sub-Saharan Africa, HIV infection has 
no known cure and can only be treated with medications meant to slow the development 
of immune system failure which results in life-threatening opportunistic infections.  HIV 
replication is fundamentally error-prone due in large part to the infidelity of the HIV 
reverse transcriptase (RT), the enzyme which produces a double stranded DNA-form of 
the single-stranded (+)RNA genome packaged in mature, infective virions.  The infidelity 
of RT leads to a high viral mutation rate (at least nine distinct HIV-1 subtypes have 
evolved) and developed resistance to chemotherapies is an ongoing struggle in the effort 
to treat those suffering from HIV/AIDS.   
Because the virus uses host cell machinery during much of its life cycle, practical 
therapeutic targets for chemotherapy are limited.  The majority of HIV medications are 
targeted toward inhibiting the functioning of either the Reverse Transcriptase enzyme 
(nucleoside or nonnucleoside analogue reverse transcriptase inhibitors (NARTIs/NRTIs 
and NNRTIs)) or HIV-1 protease, the viral enzyme that cleaves newly synthesized 
polyproteins to create the mature protein components of an infectious HIV virion.  Other 
drug therapy targets include virus attachment, membrane fusion, cDNA integration, 
virion assembly, and maturation inhibitors  ((170, 171)., (172) for a recent review.)  
Given the pandemic nature of the disease and the rapidity with which current therapeutics 
become ineffective, an ongoing research effort is vital in the treatment of HIV.   
Drugs targeted to the transactivation stage of genome transcription are a relatively 
new research effort, but make an attractive target for anti-retroviral therapy for two 
reasons.  Not only is transactivation required for efficient genome transcription (and 
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therefore production of new, infective virions) but two of the three members of the 
reactive complex involved in transactivation are viral, minimizing the potential for drug 
side effects caused by interaction with other host macromolecules.  Research devoted to 
this initiative is ongoing (173-177).  A solved structure of the interacting partners would 
provide valuable insight into the transactivation event and would greatly assist the efforts 
directed toward drug development.  So far, however, the elucidation of the structure of 
the complex has proven difficult for a number of reasons.  The goal of our project was to 
determine the structure of the immediate portions of the interacting members of the 
complex (HIV-1 Tat, human cyclin T1, HIV-1 TAR) in collaboration with and based on 
the studies of the Matija Peterlin group of the Department of Medicine at the University 
of California, San Francisco.  The Peterlin group had reported a biologically active 
minimal chimera of HIV-1 Tat and human cyclin T1 (hCycT1) capable of overcoming 
the transactivation barrier of HIV-1 Tat transactivation in murine cells.  A brief 
introduction to the transactivation components and to the work of the Peterlin group will 
explain the rationale behind our efforts.   
 
HIV transactivation 
Transcription of the full HIV genome in preparation for assembly of active virions 
proceeds in two stages.  In the first, an initiation complex forms and transcription by 
RNA Polymerase II begins.  The multimeric negative elongation factors DSIF (DRB 
(5,6-dichlorobenzimidazole 1-β-D-ribofuranoside)-sensitivity-inducing factor) and NELF 
(negative elongation factor) stall transcription of the genome near the start site, requiring 
an activation event to return RNA Polymerase II from an abortive to a productive 
complex (178).  Activation occurs when an HIV-encoded protein called Tat binds to a 
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highly structured region of the long terminal repeat portion of newly transcribed RNA.  
This binding event recruits the binding of a human regulatory factor, pTEFb (positive 
transcriptional elongation factor b), an RNA Polymerase II transcriptional elongation 
factor which consists of the protein hCycT1 and its kinase partner, CDK9 (179).  This 
three-member binding interaction results in phosphorylation events of various complex 
components including the negative elongation factors (180, 181) and the S2 position of 
the heptad repeats of RNA Polymerase II‟s carboxy terminal domain (179).  
Phosphorylation switches the initiation complex to an elongation complex, allowing 
complete transcription of the genome.  For a review of the current understanding of this 
transactivation event in CD4+ T Lymphocytes and Machrophages, see (182).  For a more 
general review of RNA Polymerase II transcriptional elongation, see (183). 
 
Transactivation complex members  
Tat.  Tat is a viral regulatory protein with multiple functions and several 
important biological interactions.  It plays a direct role in HIV induced 
immunodeficiency, including the promotion of viral infection by proliferation and 
differentiation of HIV target cells and apoptosis of T-cell lines and primary T-cells ((184, 
185); see (186) for a review of other Tat-induced biological effects.)  The sequence 
encoding Tat is comprised of two exons on different reading frames, which surround and 
partially overlap the genes encoding HIV‟s envelope gene (187).  Mature Tat requires a 
double-splicing, post-transcriptional modification that results in a protein of variable 
length (from 86 to 104 amino acids.)  While strains encoding only the first exon are fully 
active in transcriptional reporter assays, most infectious strains contain a longer 
construct, usually 101 residues in length.  It has been reported that shorter, incomplete 
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constructs may also be biologically active (186).  Tat was originally described as having 
five functional domains based on the effect of point mutations on the transactivation 
ability of an isoform containing 101 residues (188).  The domains are: N domain 
(residues 1-20), cysteine rich (21-40) Core domain (41-48, contains a conserved Lys X 
Leu Gly Ile X Tyr motif), basic domain (49-57, later called arginine-rich motif (ARM)), 
and an enhancing auxiliary domain (58-67) (see Figure C.1).  The remainder of the 
protein, comprised of the second exon, was deemed non-essential for transactivation.  
Structural (and even biochemical) studies of Tat have been confounded by the multiple 
cysteine residues within the cysteine-rich domain which can lead to misfolding (189).  
NMR chemical shifts and coupling constants indicate that Tat is a natively unfolded 
protein with only transient folding in two of the five sequence domains (190).   
Tat performs its gene expression activation role by interacting via its basic (ARM) 
domain with the HIV long terminal repeat (LTR) in a region called the Transactivating 
Response Element (TAR).  The LTR is a region of repeated sequence that flanks the 
functional genes in retroviruses.  It is important in the integration of the virus into the 
host cell genome, and also acts as a primer region for viral transcription.  The TAR 
element is especially important during the transcription of the genome in its entirety.   
TAR.  TAR (Transactivation Response Region) is a highly structured portion of 
the 5‟ LTR within the transcribed HIV genome.  It consists of approximately 60 
nucleotides that form a stable stem-loop with a 5‟, U-rich-bulge near the apex of the RNA 
stem.  The TARs from the HIV-1 and 2 isoforms differ in the position of a single cytidine 
residue (see Figure C.2) near or within the bulge region, but are otherwise highly 











                   N-domain                                 Cys-rich-- 
domain 
HIV    -------MEPVDPRLEPWKHPGSQ------------------------PKTACTN-CYCK 28 
SIV    MIDMETPLKEQENSLESYREHSSSISEVDVPTPESANLEEEILSQLYRPLEPCYNKCYCK 60 
BIV    MPGPWVAMIRLPQPKESF---GGKPIG------------WLFWNTCKGPRRDCPH-CCCP 44 
EIAV   MLN--LADRRIPGTAEENLQKSSG----------------------GVPGQNTGG--QVA 34 
                      *     ..                         *   :   : :  
 
--Cys-rich--     Core domain   ARM domain         
HIV   KCCFHCQVCFITKGLGISYG----RKKRRQRRRAPQDS-QTHQVSLS-KQPTSQPRGDPTG 83 
SIV   RCCYHCQHCFLKKGLGICY-EQH-RRRTPKKTK-TNPLPASNNRSLSTRTRNRQ       111 
BIV   ICSWHCQPCFLQKNLGINYGSG-PRPRGTRGKGRRIRRTASGEDQ                 88 
EIAV  RPNYHCQLCFL-RSLGIDYLDASLRKKNKQRLKAIQ---QGRQPQYLL---           78 
      :: :*** **: : *** *     *::  .: :            ::              
 
                                ^   ^ 
HIV P-KESKKKVERETETDPVH---      101 
SIV PKKEKKEKV-—ETEVAADLGLGR---   132 
BIV  RREADSQRSFTNMDQ---         103 
EIAV ------------- 




Figure C.1  Tat Sequence comparison  
Sequence comparison of Tat proteins from HIV (Human Immunodeficiency Virus), SIV 
(Simian Immunodeficiency Virus), BIV (Bovine Immunodeficiency Virus) and EIAV 
(Equine Infections Anemia Virus.)  The level of conservation is indicated below the 
alignment, with (.) indicating moderate conservation, (:) indicating high conservation, 
and (*) indicating universal conservation.  The proteins maintain considerable 
conservation, especially in the regions corresponding to the HIV Core and ARM 
domains, with all except EIAV showing additional conservation in the region 
corresponding to the HIV Cysteine-rich domain. 
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bound by small-molecule ligands, argininamide, and Tat-derived peptides show a 
conformational change in TAR presumably induced by binding (see Figure C.2) (191-
195).  Tat‟s binding position on TAR has been mapped to the U-rich bulge near the apex 
of the TAR RNA stem (189).  While pTEFb cannot bind TAR on its own, the affinity of 
Tat for TAR is enhanced by pTEFb (196).  The binding of hCycT1/Tat complexes to 
TAR requires conservation of bases in the loop of TAR not required by Tat alone, 
suggesting that Tat uses cooperative binding to nascent TAR to recruit hCycT1-CDK9 
complexes to RNA Polymerase II (196).   
PTEFb.  Although the CDK9 portion of pTEFb is required for transactivation, it is the 
hCycT1 portion that appears to interact with Tat/TAR.  hCycT1 is a 726 residue protein 
(approximately 87kDA) related to human CyclinC (196, 197).  In contrast to cell cycle 
cyclins such as A, B, and E, which regulate cell cycle activity through their cyclin-
dependent kinases, T-type cyclins mediate transcription by acting as a regulatory subunit 
for CDK9.  Aside from a Tat-TAR recognition motif (TRM, residues 251-271), hCycT1 
contains two conserved cyclin boxes (residues 1 to 250) as well as a coiled-coil region, a 
histidine-rich stretch, and a C-terminal PEST sequence (196).  The first 272 residues are 
sufficient to bind to Tat/TAR in vitro and to support transactivation in vivo (196, 198).  
Although a shortened hCyclinT1 construct (residues 1-250) containing only the cyclin 
boxes can still bind to Tat, it does so more weakly than constructs that contain the TRM, 
and cannot transactivate HIV transcription in vivo (199).  The structure of the cyclin box 
domain portion of hCycT1 has been solved alone (200) and with its CDK9 partner (201).  
The Tat/hCycT1 interaction is zinc mediated, and requires multiple Tat 
cysteines/histidines from within the 1-48 residue region as well as a critical cysteine   
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A.                                      B. 










Figure C.2  HIV TAR 
A.  Comparative sequences of the TARs from BIV, SL1 of SIV, HIV-2, HIV-1, and 
EIAV.  Bulge and loop regions are shown in bold type and are indicated above the 
alignment. 
B.  Secondary structure schematic of HIV-1 TAR. 
C.  Major groove view of free HIV-1 TAR RNA (left) and HIV-2 TAR RNA in its Tat-
bound configuration (right, Tat not shown). The conformation change involves 
interactions between residues A22, U23 and G26 (shown as sticks) and an arginine side-
chain from Tat (not shown).  Reprinted from J. Mol. Biol. Tackling Tat, 293, 235-254., 






residue (C261) from the TRM of hCycT1 (202).   
 
Transactivation and murine cells 
Multiple barriers inhibit full HIV-1 infection in murine cells, and one such barrier 
is the ability to produce full length genomic transcripts.  Murine cells such as CHO and 
NIH-3T3 do not support Tat transactivation of HIV transcription (203, 204).  
Overexpression of hCycT1 in the murine cell line NIH3T3 strongly enhances 
transcription from an integrated proviral HIV-1 promoter, although it does not completely 
overcome the inability of murine cells to fully support HIV-1 infection (202).  In murine 
cyclin T1 (mCycT1), position 261 is a tyrosine rather than a cysteine, and although 
mCycT1 can form a weak, zinc-independent complex with HIV-1 Tat, the ability of 
mCycT1/Tat to bind HIV-1 TAR is greatly reduced compared to hCycT1/Tat, and 
mCycT1 cannot support HIV Tat transactivation in vitro or in vivo (196, 202).  The 
Y261C mutation of mCycT1 creates the high-affinity, zinc-dependent binding to HIV-1 
Tat/TAR characteristic of hCycT1 in in vitro assays and supports Tat transactivation in 
vivo (199, 202).  Likewise the C261A substitution in human CycT1 has been shown to 
abolish binding to TAR and renders the protein unable to support transactivation (199, 
205).  This variation provides an excellent system for measuring transactivation. 
 
Defining a minimal chimera for transactivation 
With the end goal of defining a minimal construct for future structural studies, 
Fujinaga et al. constructed a plasmid containing the HIV-1 LTR linked to the CAT 
reporter gene to compare the transactivation ability of a series of fusion proteins.  They 
showed that a fusion protein of the first 280 residues of hCycT1 and full-length HIV-1SF2 
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Tat (1-101) was capable of both binding TAR in vitro and transactivating transcription of 
the HIV LTR in murine cells at a level equal to jointly expressed unfused proteins (205).  
They further reported that a much shortened construct consisting of hCycT1 (249-280) 
and Tat (1-101) supported Tat transactivation, indicating that the fusion protein interacted 
with TAR in vivo, and that both hCycT1 and mCycT1 were able to supershift Tat-bound 
TAR in EMSA assays (205).  Based on their recommendations, we began studies of even 
more truncated chimeric constructs containing shortened Tat regions and linkers.  Our 
project goals were to express and purify the minimal chimera of hCycT1 and Tat for 
structural studies alone and in complex with HIV-1 TAR.  
 
Project Results 
Although we pursued purification of multiple constructs with a variety of methods 
of cell growth, induction, and purification schemes in an attempt to optimize yield of 
recombinant chimera, yield was poor, and we lost product during each of the 
purifications steps.  Apart from the difficulties inherent to structural studies of the 
transactivation complex and to chimeric proteins in general, recent insights from related 
projects show that a well-defined structure of the minimal chimera may not be possible 
without the binding of TAR and CycT1, and that a construct redesign would be essential 
to form a structurally relevant chimeric proteint.  
Purification of the cyclin T1/Tat construct was complicated by a number of 
factors.  The construct is a minimal chimera rather than a native protein, and the core of 
the chimera is presumed to be the zinc-mediated interface between the proteins.  Since 
initial studies of the purified protein showed that the chimera was underpopulated by zinc 
despite zinc availability during protein expression and purification, it is likely that the 
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two halves of the chimera are not “bound together” outside of the presence of TAR.  
Additionally, as a free protein, HIV-1 Tat is generally believed to be natively 
unstructured (190).  Intrinsically unstructured proteins have very different characteristics 
than their well-folded counterparts, and often require different techniques for purification 
and study.  As described in a recent issue of Protein Expression and Purification,   
Expression and purification of unstructured proteins or peptides…is not trivial. 
Because of the lack of well defined structure, their solubility is generally poor and 
it is easy to form inclusion bodies during expression or aggregates during 
purification.  (206) 
A recent report of a crystallographic structure of the cyclin box domain (residues 8-263) 
of hCycT1 on the other hand, shows that the protein, including the Tat/TAR recognition 
motif, is well-structured.  Identification of an efficient method of expression and 
purification of a Tat/hCyclin T1 chimera must therefore consider the different character 
of its component parts, as a chimera may contain both structured (hCycT1) and 
unstructured (Tat) regions.  Study of the HIV Tat protein is additionally complicated by 
its unique amino acid profile, particularly in the cysteine-rich region.  Researchers who 
have studied both the HIV and EIAV CycT1/Tat/TAR systems noted in a recent paper 
that the multiple cysteines located in this short region of HIV-1 Tat make purifying the 
recombinant protein difficult, with complications in both expression and protein folding 
(207).  Another complicating factor in purification is the arginine-rich motif (ARM) of 
Tat.  The ARM is comprised of a number of basic residues, which presumably make the 
construct more soluble, but also acted to create complications.  The chimeric construct 
binds nucleic acid extremely well, to the extent that protein quantification by calculation 
at A=[280] nm was impossible until after a purification step by ion exchange 
chromatography.  Gel analysis of the elution fractions showed that ion exchange always 
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resulted in some protein loss.  Additionally, the ability of the chimera to bind nucleic acid 
complicates the issue of specific TAR binding. 
Transactivation studies and band shift assays by the Peterlin group indicate that 
constructs containing larger portions of hCycT1 were more functional than their more 
minimal counterparts (205).  The transactivation assays imply that the relative success 
could be due to superior expression or folding, while band shift data show that larger 
constructs are actually more successful in binding TAR in EMSA assays.  In fact, 
unpublished data from EMSA assays not available to us at the beginning of the project 
indicate that the constructs with shorter Tat regions may not form distinct or homogenous 
species when binding to TAR, if they bound at all.  Whereas larger constructs containing 
the cyclin box and TRM domains of cyclin T1 as well as full length Tat (hCycT1 1-
280/Tat 1-101) formed distinct bands in TAR binding assays, constructs containing only 
the TRM of cyclin T1 (hCycT1 249-280/Tat 1-101) formed smeared bands with indistinct 
borders; truncating Tat (hCycT1 249-280/Tat 1-60) resulted in very smeared bands of 
questionable density.  Without the formation of distinct, homogeneous complexes, 
structural studies would be virtually impossible.  Published studies that indicate that the 
CycT1 cyclin boxes as well as the TRM bind Tat and that both are important in 
positioning Tat for optimal TAR binding support this hypothesis (205).  
 
Insights from the EIAV system 
The recently reported structures of the hCycT1 cyclin boxes and the equine 
cyclinT1 (eCycT1) cyclin boxes/EIAV Tat/EIAV TAR complex provide insight into the 
hCycT1/Tat/TAR system, and may help in the design of future constructs for structural 
study.  EIAV is a lentivirus that infects horses and causes Equine Infectious Anemia.  
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The EIAV retrovirus is similar to HIV in terms of structure and replication pathway, and 
like HIV, genome transcription requires the recruitment of the host cell pTEFb by an 
interaction of the viral Tat protein with the TAR element within the viral LTR (208).  In 
the reported structures, hCycT1was solved as a fusion protein of hCycT1 (1–281) and 
EIAV Tat (22–78) with a 20 residue linker (GGT(GGGS)3GGGTS) (200).  The crystal 
structure showed density for the region hCycT1(8-263), but no density for the linker or 
EIAV Tat.  The eCycT1 was also solved as an EIAV fusion protein, encompassing the 
residues eCycT1 (1-281)-GGGTS-EIAV Tat (13-69), for which density was observed for 
residues 5-267/4-263 (differences for individual members of the crystallographic dimer) 
for eCycT1 and residues 41-69 for EIAV Tat (207).  Both the human and equine 
constructs contained the mutation R256W to increase protein stability.   
Based on the structural and sequential conservation between the two systems, it is 
extremely likely that the hCycT1/HIV Tat/TAR complex functions similarly to the 
eCycT1/EIAV Tat/TAR complex in the structural foundation that leads to transactivation.  
The cyclin box domains of equine and human cyclin T1 are very similar (see Figure C.3), 
with a sequence identity of 98% and a structural RMSD of 1.6 Ǻ as determined by 
DaliLite calculations (65).  EIAV and HIV Tat and TAR are more divergent, but contain 
sequence identity in key regions, indicating that the transactivation complex of HIV 
functions similarly.  In the solved structure of the EIAV complex, the observable portion 
of the chimeric EIAV Tat encompasses the region that corresponds to the HIV Tat ARM 
as well as the sequences immediately preceeding and following it.  The residues 
preceeding the ARM correspond to the C-terminal half of the core domain.  The ARM 






Figure C.3  The EIAV transactivating complex 
A.  Structural overlay of the solved cyclin boxes of equine and human cyclin T1.  The 
hCycT1 cyclin box (pdb code 2PK2) is shown overlayed with the complex of EIAV TAR 
and a chimera of the eCycT1 cyclin boxes with a fragment of EIAV Tat (pdb code 
2W2H).  The eCycT1 cyclin box domains are colored in pale cyan (box1) and cyan (box 
2) with C261 shown in sticks and colored green.  The hCycT1 cyclin box domains are 
colored pink (box1) and red (box 2) with C261 in yellow.  A portion of EIAV Tat, solved 
as a chimera with the eCycT1 box domain, is shown in blue, and is shown interacting 
with a short portion of EIAV TAR.  Overlayed structures are nearly identical with a 
sequence identity of 98% and an RMSD of 1.6 as determined by DaliLite calculations 
(65).   
B.  Alignment of equine, human, and murine cyclin T1 proteins (1-300).  The sequence 
alignment was created using ClustalW.  The identity of the proteins are indicated (E, 
equine; H, human; M, murine.)  The degree of conservation among the three proteins is 
indicated below the aligned sequences as follows:  (*), total conservation; (:), high 
conservation; (.), moderate conservation.  The five helices of the first cyclin box and the 
C-terminal helix (HC, Tat/TAR recognition motif) as determined by the solved structures 
of human and equine proteins are indicated and labeled below the sequences (H1-H5, 
HC, respectively) (200, 207).  Above the sequence are indicated residues that in the 
equine protein interact with Tat/TAR in a distance shell smaller than 4 Å ((207), 
supplementary information, indicated with a T) or that in the human protein interact with 
Cdk9 within a 3.5 Å distance ((201), indicated with a C.)  The proteins are very well 
conserved throughout, especially in the region of the first cyclin box.  The residues that in 
the equine and human protein structures were shown to be within a 4 Ǻ distance of 
Tat/TAR or CDK9 are universally conserved except for a three residue stretch located 
just N-terminal to helix H3, and except for position 261, which in the murine cyclin T1 is 
a tyrosine.  The EIAV Tat recognition loop (TRL) of eCycT1 (as described in (207) is 
also indicated.  The 79,80 positions are highlighted, which interact with bases in the loop 
region of EIAV TAR.  The authors surmise that the smaller residues (PG) in HIV TAR 
may create a pocket for the larger G34 residue in HIV TAR which has been shown to be 




           
B. 
            C    C                            T  TT  T 
E.     MEGERKNNNKRWYFTREQLENSPSRRFGLDPDKELSYRQQAANLLQDMGQRLNVSQLTIN 60 
H.     MEGERKNNNKRWYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTIN 60 
M.     MEGERKNNNKRWYFTREQLENSPSRRFGVDSDKELSYRQQAANLLQDMGQRLNVSQLTIN 60 
       ****************************:*.***************************** 
                                             H1                      
                                     
                   C   CCTTT       C   C    C CC   T  TT TTTTTTT 
E.     TAIVYMHRFYMIQSFTQFHRNSVAPAALFLAAKVEGQPKKLEHVIKVAHACLHPQESLPD 120 
H.     TAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPD 120 
M.     TAIVYMHRFYMIQSFTQFHRYSMAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPD 120 
       ******************   *:************ *************:********** 
           H2                    H3                 H4      TRL       
 
               T       C    C   C C       
E.     TRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYFMATN 180 
H.     TRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYFMATN 180 
M.     TRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYFMATN 180 
       ************************************************************ 
                   H5 
 
E.     SLHLTTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHE 240 
H.     SLHLTTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHE 240 
M.     SLHLTTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHE 240 
       ************************************************************ 
 
                 T T       X    
E.     FLQILEKTPNRLKRIWNWRACEAAKKTKADDRGTDEKTSEQTILNMISQSSSDTTIAGLM 300 
H.     FLQILEKTPNRLKRIWNWRACEAAKKTKADDRGTDEKTSEQTILNMISQSSSDTTIAGLM 300 
M.     FLQILEKTPSRLKRIRNWRAYQAAMKTKPDDRGADENTSEQTILNMISQTSSDTTIAGLM 300 
       *********.***** **** :** ***.****:**:************:********** 
                      HC                         
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EIAV proteins (see Figure C.1).  In the EIAV structure, the ARM-corresponding region 
forms a helix that inserts into the uppermost major groove of the TAR element in the 
stem/loop region, interacting with both bases and phosphates.  Although the sequence of 
the TARs are otherwise divergent, EIAV and HIV TARs contain a three base stretch of 
sequence similarity in the stem below the loop, encompassing A6, G7, and A8 on the 5‟ 
side of the EIAV stem loop and A22, G26, and A27 of the HIV stem (spanning the 5‟ 
bulge) (see Figure C.4).  The ARM-corresponding helix of EIAV Tat has a series of basic 
residues (Lys50, Gln54, and Lys57) on one side of the helix poised to interact with the 
A6-G7-A8 phosphate backbone of EIAV TAR.  Two residues on the opposite side of the 
helix (K51 and R55) interact with bases in the loop region of TAR (G16 and U13, 
respectively (Figures C.4 and C.5).  These residues and bases are all completely 
conserved in the HIV system, unlike in the comparative regions of the Simian 
Immunodeficiency Virus (SIV) and Bovine Immunodeficientcy Virus (BIV) Tat proteins.  
The eCycT1 Tyr37 residue is poised to interact with the backbone of G16 of TAR.  When 
the solved hCycT1 structure is overlaid with the eCycT1 structure, the corresponding 
residue is in a nearly identical position.  In the EIAV system, these interactions position 
residues in the loop to enable a tripartate interaction between eCycT1, EIAV TAR, and 
EIAV Tat.  The interaction involves residues His79 and Arg80, two of the only three 
residues not conserved between the first 280 residues of hCycT1 and eCycT1.  The 
differences between the EIAV and HIV TAR loops (EIAV has a tetraloop and HIV a 
hexaloop) and stems (HIV but not EIAV has a bulge on the 5‟-side of the TAR stem) are 
likely accounted for by the differences in the Tat and cyclin T1 proteins.  As described by 






Figure C.4  Comparison of the TAR RNA stem-loop regions from EIAV and HIV-1.  
A) and B) views of the interaction between the visible part of the equine Tat that was 
solved as a chimera with eCycT1, and equine TAR.  The view in B) is rotated 
approximately 90˚ about a vertical axis with respect to the view in A).  Both views are 
shown as cartoons with the TAR element colored orange.  The A7-G8-A9 region is 
colored red.  The backbone of these bases is in proximity to basic residues on one side of 
the Tat ARM helix, which are colored blue.  Extending from the opposite side of the 
helix are basic residues that are colored green (Lys51 and Arg55) and that interact with 
bases in the loop region (G16 and U13, respectively, colored yellow.) 
C)  Alignment of the core and ARM domains of Tat from HIV, EIAV, SIV, and BIV.  
Residues that in the EIAV complex structure were poised to interact with the backbone of 
bases in the A7-A9 TAR region (and corresponding HIV Tat residues) are shown in blue 
text.  Residues that were shown to interact with EIAV loop residues (and corresponding 
HIV Tat residues) are shown in green text.  The four residue insert of EIAV Tat between 
the core and ARM domains that is not present in HIV Tat is highlighted in yellow. 
D) and E)  A comparison of EIAV and HIV TAR elements, respectively.  The secondary 
structure of the TAR elements are shown.  D) EIAV TAR encompasses a 22 nucleotide 
stem-loop structure with two U-G wobble base pairings preceding the loop section.  Red 
circles indicate bases with backbone proximity to residues from the ARM region of 
EIAV Tat in the solved structure.  Yellow circles indicate bases that interact with EIAV 
Tat in the structure.  Open triangles indicate bases listed by the author to have phosphate 
interaction with EIAV Tat.  E)  HIV-1 TAR has a hexameric loop and a 3-mer bulge in 
the 5‟ strand side of the stem.  The boxed region of the TAR stemloops shows similar 
sequences.  The arrow at the base of the HIV loop indicates the residue known to be 
critical to hCyclinT1 binding.  D) and E) are adapted by permission from Macmillan 
Publishers Ltd: [NATURE STRUCTURAL & MOLECULAR BIOLOGY] (Anand, K., 
Schulte, A., Vogel-Bachmayr, K., Scheffzek, K., and Geyer, M., (2008) Structural 
insights into the Cyclin T1–Tat–TAR RNA transcription activation complex from EIAV, 




A.         B. 
           
C. 
<--Cys-rich--     Core domain   ARM domain         
HIV   KCCFHCQVCFITKGLGISYG----RKKRRQRRRAPQDS-QTHQVSLS-KQPTSQPRGDPTG 83 
EIAV  RPNYHCQLCFL-RSLGIDYLDASLRKKNKQRLKAIQ---QGRQPQYLL---           78 
                              RKK51 QR55+ 
BIV   ICSWHCQPCFLQKNLGINYGSG-PRPRGTRGKGRRIRRTASGEDQ                 88 
SIV   RCCYHCQHCFLKKGLGICY-EQH-RRRTPKKTK-TNPLPASNNRSLSTRTRNRQ       111 
 
D.         E. 
          




























Figure C.5  The TAR interacting residues of the EIAV Tat ARM 
EIAV Tat and TAR are displayed in cartoon form and colored as described in Figure C.5.  











(Asp45 Ala46 Ser47 Leu48) between the core domain and ARM domain that is not 
present in HIV Tat.  The HIV TAR bulge is likely positioned to correspond to the four 
residue Tat deletion, maintaining the positional conformation of the conserved flanking 
core and ARM domains, and further contributing to specific protein/RNA interactions.   
Despite the differences between the systems, the similarities indicate that the 
structural foundation for transactivation for HIV will mirror the EIAV system.  If so, our 
minimal construct, which contained only residues 249-280 of hCycT1, was missing the  
majority of the regions that are involved in HIV Tat/TAR interaction, and was probably 
not adequate to form distinct, homogeneous, tightly binding complexes necessary for 
structural studies of the transactivating trio.   
The 249-263 residue region of hCycT1 forms a helix at the C-terminal end of the 
second cyclin box in the solved structure (200).  The helix, called helix Hc by the 
authors, corresponds to the Tat/TAR recognition motif.  In the EIAV transactivating 
system, in addition to the critical Cys261, this helix contains two residues that were 
shown to interact with Tat/TAR, whereas 18 residues in cyclin box 1 are within 4Ǻ 
distance shell of its Tat/TAR partners (207).  Based on the insights from the reported 
structures of hCycT1 and the EIAV transactivating complex, the 249-280 residue region 
of hCycT1, corresponding to the single helix Hc, would not likely be sufficient to 
describe the transactivating complex or to enable the formation of homogenous 
representative units sufficient for structural studies.   
 
Future directions 
While the reported structure of the EIAV transactivating complex provides 
insights into the corresponding HIV system, the differences between the two (including 
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the bulge and larger loop of HIV TAR and the additional cysteines of the cysteine-rich 
domain of HIV Tat) are sufficient to indicate that a structure of the HIV system would be 
beneficial for the rational design of small molecules targeted to the tripartate 
transactivating complex.  The EIAV complex structure indicates that a redesign of 
hCycT1/HIV Tat chimera is probably required for successful studies of the HIV 
transactivating complex.   
EIAV Tat has far fewer cysteines in the region corresponding to the HIV Tat 
cysteine-rich domain, and the projected EIAV complex is expected to form a single zinc 
finger-like interface between EIAV Tat and eCycT1, as opposed to the transactivating 
complexes of other immunodeficiency viruses like HIV, which are believed to require 
two zinc atoms to form the Tat/CyclinT1 interface.  Despite the simplification of the 
EIAV Tat/CyclinT1 interface, however, the authors of the paper of the reported 
transactivating complex structure were unable to detect density for the cysteine-rich 
region of Tat or the interaction between the TRM of eCycT1 and EIAV Tat.  The system 
was constrained by the requirements of the formation of the crystallographic dimer, 
which required a relatively short RNA construct, and may have been the cause of the lack 
of density for the TRM/Tat interaction.   
Perhaps a longer RNA construct could be used in the elucidation of a complex 
structure if NMR were used to study the complex.  To reduce the signal overload inherent 
to NMR studies of large constructs, it may be possible to create a construct containing 
only the first (and not second) cyclin box of hCycT1.  The hydrophobic face of cyclin 
box 1, normally interfaced with cyclin box 2 could possibly be protected by a well-
designed linker that included important residues from cyclin box 2 that are normally 
142 
poised to interact with cyclin box 1.  This linker could connect to the TRM (residues 249-
280) known to be required for Tat interaction.  Based on the successes and limitations of 
the reported EIAV chimera, the HIV transactivating chimera could include a linker and 
portion of HIV Tat similar in length to that described by the EIAV structure.   
The success of the minimal chimera from the Peterlin studies in transactivating 
the transcription of the LTR in murine cells indicates that such a chimera could be 
successful.  The smallest constructs described in the published studies contained only the 
249-280 portion of hCycT1, which roughly corresponds to the TRM, and which forms a 
helix in the solved structures of hCycT1.  EMSA studies by the Peterlin lab showed that 
the minimal construct bound to TAR, and was capable of binding to exogenous mCycT1 
or hCycT1.  A chimera containing an additional five residues of cycT1 (244-280) resulted 
in a drop in the level of transactivation from 150-fold over baseline levels to only 50-fold 
over baseline compared to a construct containing residues (249-280) of hCycT1.  The 
hCycT1 structure indicates these additional five residues consisted of a turn and the C-
terminal end of the preceding helix.  Additionally, EMSA data showing that the 
hCycT1(249-280)-Tat construct bound both human and murine cyclinT1, indicating that 
chimera-directed transactivation in murine cells is accomplished through the recruiting of 
exogenous cyclinT1, in which the 249-280 helix is displaced.  Together, these 
observations indicate a good potential for success in structural studies of a chimera.  The 
purification scheme undertaken in the successful EIAV transactivating complex study 
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